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Abstract 
 
    Microalbuminuria have shown to be strongly predictive of subsequent 
development of diabetic nephropathy, and diabetic retinopathy is a leading 
cause of blindness worldwide , the risk of developing nephropathy and 
retinopathy is highest in patients with type 1  (insulin dependent) diabetes 
mellitus with onset in childhood . 
   The aim of this study is to determine the prevalence of each complication 
among young Sudanese patients < 19 years and their associated factors.                  
.  Albumin creatinine ratio was measured in 86 patients with IDDM 9 -18 
years old and fundus was examined for 48 patients of them, using latex 
agglutination turbidimetry and professional ophthalmoscope respectively, 
followed by overnight urinary albumin excretion as a confirmatory test for 
Microalbuminuria 
   Thirty-three diabetic patients (38.4%) had microalbuminuria defined as 
albumin / Creatinine ratio of 30ug/mg creatinine and 15-150 ug/min albumin, 
twenty-three of these patients were over 13years of age. This gives a 
frequency of MAU of 69.7% (23/33) in diabetic children and adolescents in 
the age group 13 -18 years. 
   Microalbuminuria was positively correlated with the level of glycosylated 
hemoglobin (HbA1c)   (P=0.007) .There was no gender predilection shown. 
The duration of DM, & the arterial blood pressure had no effect on the 
development of MAU.   
     Background retinopathy in terms of microaneurysms and exudates (soft 
and hard) were found in the fundus of three (6.4%) diabetic females of the 
eighty-four patients who under went ophthalmic examination. All of them 
were ≥15 years old with duration more than nine years and had a high 
systolic and diastolic arterial blood pressure. There were significant 
correlations with duration of diabetes (p= 0.001), pubertal stage (p = 0.026), 
and joint stiffness (p = 0.008), no association with glyceamic control and 
microalbuminuria is not a confounder of diabetic retinopathy.  
    This study revealed a high prevalence of microalbuminuria, and the 
prevalence of retinopathy in young Sudanese patients with Insulin-dependent 
diabetes mellitus, and emphasized the importance of strict glyceamic control 
and recommends a routine screening for microalbuminuria and retinopathy 
after the age of twelve years. 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 ﺑﺴﻢ ﺍﷲ ﺍﻟﺮﺣﻤﻦ ﺍﻟﺮﺣﻴﻢ
 ﻣﻠﺨﺺ اﻟﺪراﺳﺔ
 ﺍﻟـﺴﻜﺮﻱ  ﺑـﺎﻋﺘﻼﻝ ﺍﻟﻜﻠﻴـﺔ ﺍﻹﺻـﺎﺑﺔ  ﻟﺘﻄﻮﺭ ﺗﻨﺒﺆﻱﺍﻟﺒﻴﻠﺔ ﺍﻟﺰﻻﻟﻴﺔ ﺍﻟﺪﻗﻴﻘﺔ ﻣﻌﻴﺎﺭ      ﺗﻌﺘﺒﺮ 
 ﻓـﻲ  ﺍﻟﻌﻤﻰ ﺃﺳﺒﺎﺏ ﺃﻫﻢ ﻣﻦ ﺍﻟﺴﻜﺮﻱﻋﻠﻤﺎ ﺑﺎﻥ ﺍﻋﺘﻼﻝ ﺍﻟﺸﺒﻜﻴﺔ  ،ﺍﻟﺴﻜﺮﻱﻭﺍﻋﺘﻼﻝ ﺍﻟﺸﺒﻜﻴﺔ 
 ﻭ ﺍﻋـﺘﻼﻝ ﺍﻟـﺸﺒﻜﻴﺔ ﻱﺍﻟـﺴﻜﺮ  ﺑـﺎﻋﺘﻼﻝ ﺍﻟﻜﻠﻴـﺔ ﺍﻹﺻﺎﺑﺔﻳﺰﻳﺪ ﺍﺣﺘﻤﺎﻝ   ﻭ ، ﺍﻟﻌﺎﻟﻢ  ﺇﻧﺤﺎﺀ ﻛﻞ
  ﺧﻼﻝ ﻓﺘـﺮﺓ   ﺑﺎﻟﻤﺮﺽ ﺃﺻﻴﺒﻮﺍﻠﺬﻳﻦ ﻟ( ﺍﻷﻧﺴﻮﻟﻴﻦﻣﻌﺘﻤﺪ  )ﺍﻟﺴﻜﺮﻱ ﻣﻊ ﻣﺮﺿﻰ ﺩﺍﺀ ﺍﻟﺴﻜﺮﻱ
                                                                                                      .ﺔ ﺍﻟﻄﻔﻮﻟ
 ﻭﺳﻂ ﺍﻟﻤﻀﺎﻋﻔﺘﻴﻦ ﻫﺎﺗﻴﻦ ﻦﺍﻟﻬﺪﻑ ﻣﻦ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ ﻫﻮ ﺗﺤﺪﻳﺪ ﺍﻧﺘﺸﺎﺭ ﻛﻞ ﻣ          
                      . ﺍﻟﻤﺼﺎﺣﺒﺔﻋﻮﺍﻣﻠﻬﻤﺎ ﻭ(ﺍﻗﻞ ﻣﻦ ﺗﺴﻌﺔ ﻋﺸﺮ ﻋﺎﻣﺎ )ﺍﻟﻴﺎﻓﻌﻴﻦﺍﻟﻤﺮﺿﻰ ﺍﻟﺴﻮﺩﺍﻧﻴﻴﻦ 
ﻟﺴﺖ ﻭﺛﻤﺎﻧﻮﻥ ﻣﺮﻳﻀﺎ (   ﻟﺤﻤﻴﻨﻴﻦﺇﻟﻰﻣﺼﻠﻴﻦ ) ﻛﺮﻳﺘﻨﻴﻦ ﺇﻟﻰﺃﻟﺒﻮﻣﻴﻦﺗﻢ ﻗﻴﺎﺱ ﻣﻌﺪﻝ 
،  ﻋﺸﺮ  ﻭﺍﻟﺜﺎﻣﻨﺔﺔ  ﺑﻴﻦ ﺍﻟﺘﺎﺳﻌﺃﻋﻤﺎﺭﻫﻢ ﺗﺘﺮﺍﻭﺡ(ﺍﻷﻧﺴﻮﻟﻴﻦﻣﻌﺘﻤﺪ  )ﺍﻟﺴﻜﺮﻱﻣﺼﺎﺑﻮﻥ ﺑﺪﺍﺀ 
 (ﻟﺜﻤﺎﻧﻴﺔ ﻭ ﺍﺭﺑﻌﻮﻥ ﻣﻨﻬﻢ) ﺍﺧﺘﺒﺎﺭ ﻟﻘﻌﺮ ﺍﻟﻌﻴﻦ ﺇﺟﺮﺍﺀﻛﻤﺎ ﺗﻢ،ﺑﺎﺳﺘﻌﻤﺎﻝ ﻣﻘﻴﺎﺱ ﺍﻟﻜﺪﻭﺭﺓ ﺍﻟﻠﺜﻰ
 ﻛﺎﺧﺘﺒﺎﺭ ﺗﺎﻛﻴﺪﻯ ﺍﻟﻠﻴﻠﻲ ﺃﻟﺒﻮﻣﻴﻦ ﺇﺧﺮﺍﺝ ﺑﺎﺧﺘﺒﺎﺭ ﺇﺗﺒﺎﻋﻬﻢﻢ ﺛ،ﺑﺎﺳﺘﺨﺪﺍﻡ ﻣﻨﻈﺎﺭ ﻗﻌﺮ ﺍﻟﻌﻴﻦ
        .                                           ﺔﺍﻟﺰﻻﻟﻴﺔ ﺍﻟﺪﻗﻴﻘﺔ ﺒﻴﻠﻟﻮﺟﻮﺩ ﺍﻟ
 ﻭﺟـﺪ ﺕ ﻋﻨـﺪﻫﻢ ﺍﻟﺒﻴﻠـﺔ ﺍﻟﺰﻻﻟﻴـﺔ %( 4.83 )ﺍﻟﺴﻜﺮﻱﺛﻼﺙ ﻭﺛﻼﺛﻮﻥ ﻣﻦ ﻣﺮﺿﻰ           
 ﻣﻴﻜﺮﻭﺟﺮﺍﻡ03= ﻛﺮﻳﺘﻨﻴﻦ ﺇﻟﻰ ﺃﻟﺒﻮﻣﻴﻦ   ﺍﺳﺘﺨﺮﺍﺝ ﻣﻌﺪﻝ ﺇﻧﻬﺎ ﻋﻠﻰ  ﺍﻟﺘﻲ ﺗﻌﺮﻑ ،ﺍﻟﺪﻗﻴﻘﺔ 
ﺛـﻼﺙ ﻭ  ،ﻓﻲ ﺍﻟﺪﻗﻴﻘـﺔ   ﺃﻟﺒﻮﻣﻴﻦ ﻣﻴﻜﺮﻭﺟﺮﺍﻡ051- 51 ﻭﺃ  ﻛﺮﻳﺘﻨﻴﻦ ﺠﻢﺃﻟﺒﻮﻣﻴﻦ  ﻟﻜﻞ ﻣﻠ 
  ﺗـﺮﺩﺩ  ﻳﺰﻳﺪ ﻫﺬﺍ ﻭ. ﻮﺍ ﺍﻛﺒﺮ ﻣﻦ ﺍﻟﺜﺎﻟﺜﺔ ﻋﺸﺮ ﻣﻦ ﺍﻟﻌﻤﺮ ﻋﺸﺮﻭﻥ ﻣﻦ ﻫﻮﻻﺀ ﺍﻟﻤﺮﺿﻰ ﻛﺎﻧ 
 ﻭ ﺍﻟﻴـﺎﻓﻌﻴﻦ ﺍﻟﻤـﺼﺎﺑﻴﻦ ﺍﻷﻃﻔﺎﻝ ﻣﺠﻤﻮﻋﺔ ﻓﻲ(33/32% )7.96 ﺇﻟﻰ ﺍﻟﺪﻗﻴﻘﺔ ﻴﺔﻠﺔ ﺍﻟﺰﻻﻟ ﻴﻟﺒﺍ
                      . ﺛﻤﺎﻧﻴـﺔ ﻋـﺸﺮ ﻋﺎﻣـﺎﺇﻟـﻰ  ﻋـﺸﺮ ﺍﻟﻤﺠﻤﻮﻋـﺔ ﺍﻟﻌﻤﺮﻳـﺔ ﻣـﻦ  ﺛﻼﺛـﺔﻓـﻲ ﺑﺎﻟ ـﺴﻜﺮﻱ
،  700=ﺩﻻﻟﺔ ﺇﺣـﺼﺎﺋﻴﺔ )ﻴﺔ ﺍﻟﺪﻗﻴﻘﺔ ﺍﺭﺗﺒﻄﺖ ﺍﻳﺠﺎﺑﻴﺎ ﻣﻊ ﻫﻤﻮﻏﻠﻮﺑﻴﻦ  ﺍﻟﺴﻜﺮ ﺍﻟﺒﻴﻠﺔ ﺍﻟﺰﻻﻟ      
 ﺿﻐﻂ ﺍﻟـﺪﻡ ﻉﺃﻣﺪ ﺍﻟﻤﺮﺽ ﺃﻭ ﺍﺭﺗﻔﺎ ، ﻛﻤﺎ ﻟﻢ ﻳﺘﺒﻴﻦ  ﺍﻯ ﺍﺭﺗﺒﺎﻁ  ﺑﺎﺧﺘﻼﻑ ﺍﻟﺠﻨﺴﻴﻦ (      0
  .ﻠﺔ ﺍﻟﺰﻻﻟﻴﺔ ﺍﻟﺪﻗﻴﻘﺔﻴﺎﻟﺒﻓﻲ ﺍﻹﺻﺎﺑﺔ ﺑ
ﻭ (  ﺍﻟﺪﻗﻴﻘﺔﺎﺳﻤﻧﻮ ﺭﺍﻻ) ﺍﻟﺪﻡ ﺍﻟﺪﻗﻴﻘﺔ ﺃﻡﺍﻋﺘﻼﻝ ﺧﻠﻔﻴﺔ ﺷﺒﻜﻴﺔ ﺍﻟﻌﻴﻦ  ﻟﻮﺟﻮﺩ             ﻭﺟﺪ 
ﻣﻦ ﻣﺠﻤﻮﻉ %( 4.6 )ﺇﻧﺎﺙ ﻭﻳﻤﺜﻠﻮﻥ ﻗﻌﺮ ﺍﻟﻌﻴﻦ ﻋﻨﺪ ﺛﻼﺙ ﻓﻲ ،(ﺍﻟﻨﺎﻋﻤﺔ ﻭ ﺍﻟﺨﺸﻨﺔ  )ﺤﺎﺕﻨﺘﺍﻟ
ﻣﺴﺔ ﻋﺸﺮ ﻣﻦ ﺎ ﺍﻟﺨﻓﻲ ﺟﻤﻴﻌﻬﻦ ﻭ. ﻣﺮﻳﻀﺎ ﺍﻟﺬﻳﻦ ﺗﻢ ﺍﺧﺘﺒﺎﺭ ﻗﻌﺮ ﺍﻟﻌﻴﻦ ﻟﻬﻢﻭﺃﺭﺑﻌﻮﻥ ﺍﻟﺜﻤﺎﻧﻲ
  . ﺍﻛﺒﺮﺃﻭﺍﻟﻌﻤﺮ 
، 100= ﺣﺼﺎﺋﻴﺔ ﺩﻻﻟﺔ ﺇ ) ﺍﻟﻤﺮﺽﺃﻣﺪ ﺍﻳﺠﺎﺑﻴﺎ ﻣﻊ ﺍﻋﺘﻼﻝ ﺧﻠﻔﻴﺔ ﺷﺒﻜﻴﺔ ﺍﻟﻌﻴﻦ        ﺍﺭﺗﺒﻂ
، 800=ﺩﻻﻟﺔ ﺇﺣﺼﺎﺋﻴﺔ )ﻭﺗﻴﺒﺲ ﺍﻟﻤﻔﺎﺻﻞ(0،  620=ﺩﻻﻟﺔ ﺇﺣﺼﺎﺋﻴﺔ )ﻭ ﻣﺮﺣﻠﺔ ﺍﻟﻤﺮﺍﻫﻘﺔ(0
 . ﻠﺔ ﺍﻟﺰﻻﻟﻴﺔ ﺍﻟﺪﻗﻴﻘﺔﻴﺎﻟﺒ ﺃﻭ ﺍﻹﺻﺎﺑﺔ ﺑﻡ ﺍﻟﺪﺳﻜﺮ ﺍﺭﺗﺒﺎﻁ ﻣﻊ ﺗﻨﻈﻴﻢ ﻳﺘﺒﻴﻦ ﺍﻯﻟﻢ ﻛﻤﺎ (. 0
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Chapter one 
1.  Introduction and Literature Reviews 
1.1 General introduction: 
      Diabetes mellitus is the most common of the serious metabolic diseases. 
(1) The diabetic patients is susceptible to a series of microvascular 
complications (MVC) that cause morbidity and premature mortality .While 
some patients may never develop these problems ,others note their onset 
early, MVC may develop in puberty or early adulthood ,the longer the 
duration of DM the greater the risk of complications, which increase 
significantly following puberty .(2) 
1.2 Historical background: 
    Diabetes mellitus has both ancient roots and expanding research base. 
Polyuric state was recognized by ancient Egyptians at 1550 BC.(3)  
        The word diabetes comes from Greek word means siphon. It was 
described by the Greek physician Aretaeus at the first century. Much later at 
the seventeenth century the word mellitus from a Latin word means honey 
was added because of the sweet nature of the urine. (3) 
 At mid 18th century, diabetes was described as a systemic disease rather than 
renal disease.
      In 1893, pancreatic islets were named after Langerhans .And in 1909 the 
name insulin was given to the pancreatic glucose lowering substance. (4) 
      Insulin was discovered by collaboration work of Toronto group in 1921 
by Best C.H , Mcled J R, Banting F G, Collip J B. Ted Ryder was the first 
child to be treated with insulin. (5) 
1.3 Definition: 
        Diabetes mellitus is a syndrome of metabolic disease characterized by 
hyperglycemia .It is caused by deficiency of insulin secretion or insulin 
action, or both, and results in abnormal metabolism of carbohydrates, protein, 
and fat (6).The disease is characterized by metabolic abnormalities, long term 
complications, involving the eyes, kidneys, nerves and blood vessels; and by 
a lesion of the basement membranes demenostratable by electron 
microscopy(1) .The hallmark of diabetes is fasting hyperglycemia ,and /or post 
glucose hyperglycemia. Hyperglycemia following a glucose load generally 
precedes the development of fasting hyperglycemia. (7) 
 
 
 1.4 Classification: 
       The current classification of diabetes recommended by the National 
Diabetes Data Group is that diabetes is divided into Insulin –dependent 
diabetes mellitus (IDDM) characterized by low or absent levels of circulating 
endogenous insulin , depending on injected insulin to prevent ketosis and 
sustain life , onset predominantly in youth but can occur at any age, 
associated with certain HLA & GAD antigens, abnormal immune  response 
,islet cell antibodies are frequently present at diagnosis & partially genetic.  
     Non insulin dependent diabetes mellitus (NIDDM) in witch insulin level 
may be normal, elevated, or depressed, hyperinsulinemia and insulin 
resistance characterize most patients, insulinopenia may develop as the 
disease progresses, not insulin dependent or prone to ketosis under normal 
circumstances, may need insulin for treatment of hyperglycemia, onset 
predominantly after age 40 year, but can occur at any age properly strongly 
genetic. 
      Gestational diabetes and other types (associated disease identifiable 
condition cause or allow a diabetes syndrome to develop). (8, 9) 
      According to the American Diabetes Association, Diabetes is classified 
as: 
 Type1: Immune mediated and idiopatathic form of Beta-cell dysfunction 
leading to absolute insulinopenea. 
Type2: A disease of adult or occasionally adolescent onset, resulting from 
insulin resistance and relative insulin deficiency or from an insulin secretary 
defect. 
Type3:  Include a wide range of specific types of diabetes including the 
various genetic defects of beta-cells function, insulin action, and diseases of 
exocrine pancreas (e.g. cystic fibrosis). 
Type4: Gestational diabetes. (2)               
      The term type 1 has often been used as a synonym for insulin dependant 
diabetes (IDDM), and type 2 diabetes has been considered equivalent to non-
insulin dependent diabetes (NIDDM).This probable is not ideal since some 
patients with apparent NIDDM   may in fact be destined to become fully 
insulin dependent and prone to ketoacidosis.(1) 
1.5 Epidemiology of IDDM: 
       In the United States, the prevalence of diabetes among school age 
children is about 1.9/1,000, the frequency however is higher correlated with 
increase age, the range is 1case /1430 children at 5 years of age to 1 in 360 
children at 16 years. In relation to racial or ethnic backgrounds, there is also 
 abroad range of nearly 40 new cases/100,000 population/ year in Finland, to 
about 1/100,000 in Japan. Among black Americans, the occurrence of IDDM 
is between one third and tow third of that seen in American whites. The 
annual incidence in United States is about 12-15 new cases/100,000 of the 
child population. Girls and boys are almost equally affected, there is no 
apparent correlation with socioeconomic status. Peaks of presentation occur 
in two age groups: at 5-7years of age and at the time of puberty. 
     The first peak correspond to the time of increased exposure to infection is 
coincident with the beginning of school, the later, to the pubertal growth spurt 
induced by gonadal steroids ,increased pubertal growth hormone 
secretion(which antagonizes insulin action), and the emotional stresses 
accompanying puberty .The prevalence & incidence of IDDM in childhood in 
the united states & elsewhere may reflect the population's distribution of 
susceptibility genes encoded on the DQbeta- chain of HLA system . 
      Newly recognized cases appear with greater frequency in the autumn & 
winter months in the Northern & Southern Hemispheres. Attempts to link a 
pattern of long term   cyclicity with the incidence of mumps or other viral 
infections, have not been successful .There is however a definite increase 
incidence of diabetes in children with congenital  rubella  .These associations 
with viral infections suggest a potential role for viruses as direct or indirect 
triggering mechanisms in the etiology of diabetes. (6)  
       The magnitude of childhood diabetes in Sudan was first measured in1987.  
It is reported that, an incidence of 5.9/100,000. (10) Most recent study showed 
that the incidence is 10.1/100,000 Sudanese children under 15 year of age. (11) 
1.6 Etiology & pathogenesis of IDDM: 
      By the time IDDM appears, most of the beta-cells in the pancreas have 
been destroyed. The destructive process is almost certainly autoimmune in 
nature.  The pathogenesis of these occurs in certain sequences: First, there 
must be genetic suscepetablity to the disease. Second, an environmental event 
initiates the process in genetically susceptible individuals. Viral infection is 
believed to be a common triggering mechanism.  Thirdly, an inflamed 
response in the pancreas called (insulitis). Fourthly there is an alteration or 
transformation of the surface of the beta –cell such that it is no longer 
recognized as (self), but seen by the immune system as a foreign cell or (non-
self). The fifth step is the development of an immune response. Because the 
islets are now considered (non-self) cytotoxic antibodies develop & act in 
concert with cell mediated immune mechanisms. The end result is the 
destruction of the beta-cell & the appearance of diabetes. (1) 
     In summary, the pathogenetic sequences are, genetic   predisposition              
environmental insulitis                     conversion of   beta-cell   from (self) to 
 (non-self)             activation   of   immune system              destruction of beta-
cell                    Diabetes mellitus. 
1.6.1 Genetics: 
      Although IDDM aggregates in families, the mechanism of inheritetance is 
unclear in Mendelian terms. Transmission has been postulated to be 
autosomal dominant, recessive &mixed, but none has been proven. The 
genetic predisposition is probably permissive &not casual. Overall, the 
chance of a child developing type 1 diabetes when another first degree 
relative has the disease is only 5-10%. The presence of NIDDM in a parent 
increases the risk for IDDM in the offspring. One of the susceptility genes in 
IDDM likely resides on the sixth chromosome in view of strong associations 
of diabetes & certain human leukocyte antigens (HLA) code by the major 
histocompatibilty region on this chromosome. Four loci designated by the 
letters A, B, C &D are recognized with alleles at each site identified by 
numbers. Major alleles conferring enhanced risk for IDDM are HLA- DR3, 
HLA-DW3, HLA-DR4, HLA-DW4, HLA-B8 & HLA-B15.When compared 
with the general population the risk for IDDM imposed by the presence of 
DR-3 or DR-4 is 4-10 times. If the comparison is made not against a control 
population but against a subset of persons not bearing the predisposing 
antigen, relative risks are as high as thirty fold. However, many persons 
carrying "high risk" alleles never develop diabetes. (1) 
       Antigen B7 & DR2 (DW2) have been called "protective" since they are 
found with less frequency in diabetic subjects than in the general population 
.It is likely, however, that they are actually (low- risk) alleles rather than 
(protective) because they are present in inverse relationship with DR3/DR4 
,i.e. if DR2,DW2 is present ,high-risk alleles will be absent(1). 
1.6.2 Environmental event: 
     The best evidence that an environmental insult is required comes from 
studies in monozygotic twins, in whom the concordance rate for diabetes is 
no more than 50%. If diabetes is, only genetic disease the concordance rate 
would be 100%.  
     The environmental factor in most cases is believed to be a virus capable of 
infecting the beta-cell, which is suggested by the seasonal variation in onset 
of the disease, and what appeared to be more than a chance relationship 
between appearance of diabetes, and preceding episodes of mumps, hepatitis, 
infectious mononucleosis, congenital rubella & Coxsackie (B4) virus 
infections(1). 
1.6.3 Insulitis: 
      In animals activated T- lymphocytes infiltrate the pancreatic islet prior to 
or simultaneous with the development of diabetes .Lymphocytes are also 
 found in the islets of young person dying from new-onset diabetes mellitus, 
and radioactively labeled lymphocytes localize in the pancreas in humans 
with IDDM. These findings are in accord with the observation that immune 
endocrinopathies in general are associated with lymphocytic infiltration of 
the affected tissues (1). 
1.6.4   Conversion of the beta- cell from (self) to (non- self) & activation 
of the immune system: 
       HLA-DR3 & B15 known to be associated with immune endocrinopathies 
are found with increased frequency in insulin- dependent diabetic subjects.  
Moreover, there is frequent co-existence of IDDM & other forms of 
autoimmune endocrinopathy such as Addison's disease, Hashimoto's 
thyroiditis, hyperthyroidism, pernicious anemia, vitiligo, myasthenia gravis 
and collagen vascular disease. All of these conditions tend to run in families. 
In addition ,islet cell antibodies (ICA) are found in a high percentage of 
patients with IDDM (60- 90%) ,who are examined during the first year after 
diagnosis .These antibodies are also present in the nonconcrdant monozygotic 
twins or triplets destined to become concordant in the future .The same is true 
for siblings of patients with IDDM. ICA correlates with residual beta-cell 
mass, and it will disappear with in 2-3 years as beta-cell die (8) 
       Killer T-cells are present in 50 to 60% of recently diagnosed diabetic 
children, a value higher than in control populations. (1) 
     Glutamic acid decaboxlase antibodies (GAD) has been identified in 65-
80% of IDDM patients .Measurement of GAD antibodies may be the 
procedure of choice for screening for prediabetes & for confirming the 
diagnosis of autoimmunity as a cause of diabetes. The test may be positive 10 
years before the onset of clinical diabetes. (8, 12) 
      Insulin autoantibodies (IAA) may be present in up to 50% of patients with 
new –onset IDDM developing before age 5, (IAA) titers declines with age. . 
(8, 13) 
      What causes autoimmune process? First, there is an increase in the ratio 
of helper to suppressor T-cells in the circulation, which is likely due to 
deficiency of suppressor T-cells. An unbalanced helper T-cell population 
would predispose to exuberant antibody formation on exposure to antigen 
.Second, class II HLA molecules appear on the surface of the beta-cell. 
Activation of the helper T-cell requires the presence of class II HLA 
molecule & foreign or autoantigen .The normal islet cell does not express 
class II molecule, but in response to a virus, the cell develop such molecules, 
rendering it potentially recognizable as (non-self). Depending on the allele 
expressed, the immune system may be activated. Thus if HLA-DR2 is 
 present, it would be unlikely that diabetes would develop, & conversely if 
DR3 or DR4 or the putative DQ antigen were present, then the system could 
be activated. (1) 
1.6.5 Destruction of beta-cell & development of IDDM: 
        Because IDDM patients often have rather abrupt onset of symptomatic 
hyperglycemia with polyuria and or ketoacidosis, it was long assumed that 
beta-cell damage occurred rapidly. In many cases, there may be a slow loss of 
insulin reserve over many years. 
     The immune-directed destruction of beta cell probably involves both 
humeral and cellular mechanisms. Initially antibodies are probably dominant. 
Two types of antibodies have been identified, cytoplasmic and surface. 
Usually both are present simultaneously in a given patient but either can 
occur alone .Islet cell surface antibodies have the capacity to fix complement 
and lyses beta-cells, it impairs insulin release even before the beta-cell is 
physically damaged. At some point in the course, cytotoxic T-lymphocytes 
and antibody-dependant killer T-cells participate in & complete the 
destruction. By the time overt diabetes appears, most insulin–producing cells 
have disappeared. In one study pancreatic mass at autopsy averaged 40gms in 
type 1 DM versus 82gm in controls. Endocrine cell in subjects with IDDM 
 decreased from 1395 to 413mg & beta-cells, which averaged 850mg in 
normals, were immeasurable, since alpha cells remained initially intact. 
     At one study of  72 Sudanese  patients with type 1 diabetes mellitus  and 
healthy controls from central region of Sudan showed that the  rate of 
DR4/DQW2 haplotype occurring at increase frequency in  type1 patients and 
contribute to the overall association between DQW2 & the disease. (14)   
      Also immunological markers of type 1 diabetes were studied in 46 
Sudanese children, the cytoplasmic islet cells antibodies (ICA) & endogenous 
insulin secretion were studied in newly diagnosed diabetes. A 29 (63%) of 
the patients had ICA ,which was found to be higher than those reported for 
African population ,the ICA positive patients had significantly lower C-
peptide concentration ,higher HbA1C levels ,high insulin requirement &higher 
prevalence of DKA at presentation ,also the study showed clear association 
between ICA & severity of diabetes at clinical onset. (15)  
      Zaki M. studied the prevalence of GADA &thyroid antibodies in 
Sudanese children with IDDM, their sibs and control groups, she found that 
GADA were positive in significant titers in 46% of diabetic children, 8% of 
siblings & 3.2% of the control group, where as the thyroid antibodies were 
not detected in the sera of the three comparative group except in tow 
goiterous diabetic females. (16) 
 1.7 Clinical manifestations: 
     The classic presentation of diabetes in children is a history of polyuria, 
polydipsia, and polyphagia & weight loss. The duration of these symptoms 
varies but is often less than one month. A clue to the existence of polyuria 
may be the onset of enuresis in the previously toilet – trained child. An 
insidious onset characterized by lethargy, weakness and weight loss is also 
common. 
      Pyogenic skin infections & monilial vaginitis in adolescent females are 
occasionally present at time of diagnosis of diabetes. They are rarely the sole 
clinical manifestations of diabetes in children, & a careful history invariably 
reveals the coexistence of polyuria & polydipsia. 
      Ketoacidosis is responsible for the initial presentation of many 
(approximately 25%) diabetic children.  The early manifestations may be 
relatively mild and consist of vomiting, polyuria and dehydration, in more 
prolong and sever cases, and Kussamul’s respiration is present with an 
acetone odor on the breath. Abdominal pain or rigidity may be present & may 
mimic appendicitis or pancreatitis.  Coma may also been present. (6) 
       One study in Sudanese children with IDDM demonstrated that a sever & 
aggressive type of DKA occurring in 82% of children at presentation 
(17).Another study of a group of 70 Sudanese diabetic children presenting with 
 DKA, found that 37.1% of the patients were newly discovered & the majority 
of patients (73%) showed the classical trait of polyuria , polydipsia and  
weight loss. (18) 
1.8 Diagnosis:   
        Children, in whom the diagnosis of diabetes mellitus must be considered 
may for practical purposes, be divided into three general categories: 
1. Those who have a history suggestive of diabetes (polyuria with polydipsia 
and failure to gain or loss of weight inspite of a voracious appetite. 
2. Those who have transient or persistent glucosuria. 
3. Those who have clinical manifestations of metabolic acidosis with or 
without stupor or coma. 
      In all instances the diagnosis of diabetes mellitus dependent on the 
demonstration of hyperglycemia (FBG of 7 mmol/L OR   RBG of 11.1 mmol 
/L) association with or without Ketonuria. When classic symptoms of 
polyuria and polydipsia is associated with hyperglycemia and glucosuria, the 
glucose tolerance test is not needed to support the diagnosis. (6) 
       The discovery of glucosuria with or without mild degree of 
hyperglycemia, during hospital admission for trauma or infection or even 
 during the associated emotional upheaval may, but usually does not herald 
the existence of diabetes, these patients should be checked at a later time for 
possibility of hyperglycemia or clinical feature of DM or both. In these 
circumstances glucose tolerance test may be useful to establish a diagnosis, 
and it should be performed several weeks after recovery from the acute 
illness using a glucose loading dose adjusted for weight. Evidence indicates 
that the test is most likely to be abnormal in patients in whom ICA or IAA are 
detected, and they should be educated about the symptoms of DM. (6)  
1.9 Treatment of IDDM: 
1.9.1 Goals of treatment:- 
1.9.1.1 Normal development:  
      Normal growth in height and weight and normal timing of adolescent 
pubertal development are important goals of long term management 
.Chronically under treated children , with poorly controlled type 1 diabetes 
often fail to grow normally and have delayed skeletal maturation (bone age) , 
and delayed sexual maturation. Growth is an important factor to follow, 
height, weight, and pubertal development should be monitored carefully, and 
the causes for deviations from normal velocities should be sought. 
     Children receiving excessive insulin dose may gain weight too rapidly 
.Excessive insulin doses may also cause rebound hyperglycemia and ketosis 
can on occasion produce a similar degree of growth retardation, as can 
chronically inadequate doses  
1.9.1.2 Management of type I diabetes:- 
    Education of the patient and family with the goal of independent 
management of type diabetes at home is important , Some families achieves 
independent quickly, others requires intensive and repeated education on a 
one to one base or in a group program. Children and adolescent with IDDM 
should be encouraged to participate in many activities that are appropriate for 
their age and interests.   
    An adolescent with sports practice, three times a weak after school can 
learn how to increase calories or decrease insulin doses & keep blood glucose 
levels in acceptable range during the activity. Certain precautions must be 
taken. For example, a source of calories must be readily available during 
physical activity. 
    The diet should be designed around the child's &family's food preference 
& habits, using sound nutritional principles.  
 
 1.9.1.3 Avoiding metabolic abnormalities: 
    Blood glucose monitoring several times a day with urinary ketone checks 
are main stays of management .significant hyperglycemia & hypoglycemia 
should be avoided. Glycosylated hemoglobin levels should be monitored 
regularly, usually every 3 months, with a goal of achieving a level as close as 
to the normal range as possible. Blood lipids should be monitored & dietary 
modifications made, if hyperlipidemia occurs. 
    Ketonuria should be treated early. In most patients who monitor regularly, 
DKA can be avoided by responding to hyperglycemia, ketones, & periods of 
illness by adjusting insulin doses. 
1.9.2 Management: 
1.9.2.1 Insulin:  
    Has an effective shelf-life of at least two years if kept in a refrigerator at 4 
degree centigrade, & can be kept at room temperature for up to one month. 
However if kept in tropical climates, or freezer compartments, insulin may 
degrade more rapidly. Insulin is most commonly administered by pen-
delivery system or using syringes & needles. In general, vials of insulin are 
cheaper than insulin in pen cartridges which in turn cheaper than insulin-
filled disposable pens. For children with needle phobia, spraying –loaded 
 automatic injection devices in which the needle is not visible, or transjector 
system in which a jet of insulin is delivered at sufficiently high pressure that 
it penetrates the skin without the need for a needle may be helpful. 
    Following diagnosis, most children will require approximately 0.5 units 
per kilogram body weight daily although this may decrease substantially 
during the first few weeks of therapy (occasionally to the point where the 
patient may be transiently completely weaned of insulin) during the so-called 
honey moon period. This period, which represents partial recovery of the 
existing beta-cell mass, may last from few months up to tow years. Patients 
should be warned that insulin requirement would increase significantly at the 
end of the (honeymoon) period. 
    For most children, the use of twice-daily injections using a mixture of short 
& intermediate acting insulin in a ratio of 30:70 of approximately 70% of the 
total daily dose being given at breakfast time is suitable. Preschool aged 
children may require less short acting insulin or only intermediate-acting 
insulin. Occasionally, preschool-aged children, especially during the 
honeymoon period may only require once daily insulin prior to breakfast. For 
the appropriately motivated older, the use of basal bolus regimen with 
injections of short acting insulin prior to each main meal with injection of 
longer acting insulin prior to bedtime may be more appropriate. 
     Children initially treated at hospital are less active than at home & most 
will experience a fall in their blood glucose following discharge.  
    Once receiving insulin therapy there is often concern about high blood 
concentrations & the need for the need extra injections of insulin. If the child 
is well & in the absence of ketones, the risk of developing DKA is minimal & 
extra injection of short acting insulin are not required. If insulin concentration 
remain high, additional insulin can be given with the next scheduled injection 
(e.g. 1-2 units of short acting insulin if blood glucose is 15-20 mmol/l or 3-4 
units if blood glucose is >20mmol/l) & the preceding scheduled dose of 
insulin should be increased by 1-2 units the following day. (2) 
1.9.2.2 Diet:    
    Children should be encouraged to eat regular meals containing complex 
carbohydrates (e.g.  Potatoes & cereals), to reduce their intake of refined 
sugars, fat, salt and to increase their dietary fiber intake. No particular food 
should be considered as forbidden, as this may lead to disturbed attitude to 
food. Further more to deprive children of some foods such as sweets, which 
their friends consume regularly, may be psychologically damaging. Foods 
with carbohydrate content can be taken before exercise, incorporated into a 
main meal or used as a source of energy during illness when children have a 
poor appetite. (2) 
     Children receiving twice-daily injections of combined short and 
intermediate acting insulin require three main meals and three snacks (mid-
morning, mid-afternoon and prior to bed). Occasionally, extra snacks are 
required if there are significant delays with meal times or if the child has only 
eaten a small proportion of a mean meal. Preschool aged children may have 
unpredictable eating habits and may require frequent, small meals. 
    Children receiving a basal bolus insulin regimen do not require snacks 
between the main meals, although an evening snack is advisable as a 
precaution against nocturnal hypoglycemia. 
    Caloric intake does not need to be calculated or altered unless the child is 
over or under weight. It is recommended that the approximately 35% of 
dietary energy intake should be derived from fat (mainly mono or 
polyunsaturated fats), 15% from protein and 50% from carbohydrate. 
Carbohydrates should always provide at least 40% of the total energy 
intake.(2) 
1.9.2.3 Psychological support:  
    The diagnosis of diabetes is invariably a shock to the child and family. 
Psychological or psychiatric problems may arise particularly at diagnosis or 
during adolescence. Psychological support can be provided by a psychologist 
 or psychiatrist as well as by diabetic nurses, other parents and local and 
national groups. (2) 
1.9.2.4 Exercise: 
    Physical fitness and regular exercise are important for all patients with type 
I diabetes. Insulin requirements may be lower, metabolic control improved, 
and self-esteem and body images better in the physically fit child. During 
periods of exercise, extra calories or lower insulin doses may be needed to 
prevent hypoglycemia. Blood glucose monitoring to asses the effects of 
exercise on blood glucose and the response to these therapeutic maneuvers 
should be performed to atrive an effective regimen for individual patient. 
Regular exercise is to be encouraged at any age, because it then becomes part 
of the child health regimen. 
    When metabolic control is poor, the stress of exercise may worsen 
metabolic control. Some patients have a delayed hypoglycemic response to 
exercise, and if this response occurs, adjustment in insulin dose and calories 
become necessary. (19) 
 
 
 
 1.9.2.5 Monitoring: 
    One of the major advances since late 1970 s has been the technique of self-
monitoring glucose. Numerous reagent strips, glucose meter, and finger 
lancing devices are available. 
    Blood glucose traditionally is monitored before meals, before snacks, and 
on the middle of the night at approximately 3:00 am. Approximately four 
recorded readings a day usually provide enough information to assess and 
achieve control. During a period of metabolic instability, more frequent 
monitoring is necessary. Fasting and pre-prandial levels are in the range 70-
150mg/dl; postprandial of <200mg/dl and 3:00am values >65-80mg/dl 
indicates good control. 
    The measurement of glycosylated hemoglobin (HbA1C) level is another 
major advance in diabetic management. This objective level measures an 
average blood glucose reading over approximately two months. The method 
used in Diabetes Control and Complication Trial (DCCT), had a normal 
HbA1C range of <6.05%, studies linking chronic complications of IDDM to 
specific HbA1C levels can be related to a particular laboratory results. 
    Urinary ketones also should be monitored. Even patients who monitor 
blood glucose accurately and regularly need to check urinary ketones, 
particularly when blood glucose level>250mg/dl, when they have fever, feel 
 nausea or vomit or when they are just not feeling well. This monitoring is 
important in achieving the goal of aborting DKA episodes by treating early 
ketosis. 
    Blood lipids should be monitored periodically. Because type I diabetes is 
associated with other autoimmune disease, (especially thyroid disease.). 
Periodic monitoring of thyroid should be performed by thyroid function test 
(TFT). Patients should be seen by the health care team every 3 months. 
Regular monitoring for ophthalmologic complications and for nephropathy 
should be performed. (19) 
1.9.2.6 Education: 
    Education is fundamental to the diabetes management and control. Patients 
and families need to understand all aspects of diabetes, including acute and 
long-term complications. They must understand details of insulin action, 
include duration & timing, injection techniques, dietary information, blood 
glucose and urinary ketone checks.(19) 
1.10  Complications: 
    Insulin dependent diabetic patients are prone to acute (metabolic) and long-
term complications. 
 
 1.10.1. Acute complications: 
1.10.1.1: hypoglycemia: 
    In children with diabetes, hypoglycemia may be defined as a blood glucose 
concentration less than 4mmol/L. However, children whose glyceamic 
control is poor may experience hypoglycemic symptoms at concentrations 
above 4mmol/L if a rapid fall in glucose has occurred. 
Causes of hypoglycemia: 
     Although in up to half of cases there may be no obvious cause, 
hypoglycemia may be caused by: 
- A missed or delayed snack or meal. 
- Exercise. 
- Alcohols. 
- An overdose of insulin. 
- Impaired food absorption as a result of gastroenteritis or celiac disease 
or 
- Addison disease. 
      Hypoglycemic symptoms may be mild (i.e., adrenergic symptoms of 
tremors, sweating, hunger, palpitations), moderate (i.e. adrenergic plus nuero-
glycopenic symptoms of headache ,irritability or other mood change, 
 sleepiness, confusion, inattentiveness, impaired judgment ,weakness), or 
sever ( i.e. irresponsiveness, coma , convulsions ). Mild & moderate reactions 
can be treated by ingesting simple sugar (i.e. 10-15g of glucose). Moderate 
reactions may require assistance by another person and additional 
carbohydrates. Sever reactions require treatment with intravenous glucose or 
paranteral glucagon (0.1mg/kg to a maximum of 1.0mg intramuscularly or 
subcutaneously). All patients' families, day-care providers, teachers, and 
others should learn the signs of hypoglycemia; have a readily available 
source of glucose to treat it, ideally have, and know how to use glucaon 
injections to treat sever reactions. 
     In hospitals 2ml/kg of 10% glucose given intravenously will treat sever 
hypoglycemia. (2) 
1.10.1.2 Hyperglycemia and ketosis: 
     Patients with IDDM and their families must learn how to adjust insulin 
doses to treat the inventible hyperglycemia that occurs with IDDM or when 
to call their health care provider for assistance. Ketosis may occur 
occasionally or more frequently, and patients must know how to respond. 
 
 
 1.10.1.3 Diabetic Ketoacidosis: 
        DKA is a common and potentially life-threatening acute complication of 
IDDM. DKA is the most common cause of death in patients with IDDM 
younger than their mid-twenties. Mortality is as high as 6-10%. DKA can be 
defined as , a blood glucose level usually greater than 250mg/dl, PH equal or 
less than 7.2 and plasma bicarbonate level of 15 mmol/L or less. Sever DKA 
is defined as a PH of 7.1 or less and a bicarbonate level of 10 mmol/L or less. 
Milder forms may be seen. Careful monitoring of blood glucose and urinary 
ketones and appropriate treatment responses to early metabolic abnormalities 
can prevent a significant number of DKA episodes in patients with 
established IDDM. (19) 
      The basic cause of DKA is absolute or relative insulin deficiency. 
Elevated levels of counter regulatory or stress hormones (e.g. glucagon, 
cortisol, growth hormone, and catecholamine) are present. These hormonal 
abnormalities produce hyperglycemia (by increased glucose production and 
decreased use ), which leads to an osmotic diuresis and dehydration , lipolysis 
and hyperlipidemia, acidosis caused by the production of ketones(i.e. 
actoacetate , beta - hydroxybutyrate) from fatty acids , and electrolyte 
abnormalities caused by intracellular- extra cellular shifts and urinary losses. 
       The usual manifestations of DKA include a history of classic signs and 
symptoms of polyuria, polydipsia, and weight loss, after patients sufficiently 
ketotic and acidotic; they have a fruity breath odor or ketosis. Many also 
exhibit nausea, vomiting, and lethargy. State of consciousness may vary from 
a wake and alert to drowsiness and coma. Hyperventilation and dehydration 
also occur. Abdominal pain and an elevation in leucocytes may be caused 
solely by DKA and may be confused with an acute abdomen. These clinical 
finding usually resolve with therapy of DKA, but if not, an underlying cause 
(e.g. appendicitis) must be sought. DKA must be considered in children who 
are vomiting and appear dehydrated but continue to urinate excessively. 
    In a known diabetic, DKA may be precipitated by an acute infection, but it 
usually is caused by omission of insulin that may be deliberate or based on a 
misconception that insulin dose should be eliminated or significantly 
decreased because of anorexia or vomiting. 
    Recurrent DKA in most cases is now thought to be caused by deliberate 
insulin omission, sometimes by a child without the parents' knowledge and 
sometimes by the child and parents in collusion putting a responsible adult in 
charge of insulin injection and using a simplified regimen (e.g. two shots per 
day) may be successful in lowering the number of or eliminating the DKA 
episodes. 
     The degree of hyperglycemia does not necessarily correlates with the 
degree of acidosis, and patients may be severely acidotic but only minimally 
hyperglycemic. 
    The basic component of DKA treatment is fluids and electrolyte 
replacement (with careful attention to potassium) and insulin, which must be 
performed with frequent monitoring of clinical and laboratory factors. (19) 
1.10.2     Long-term complications:     
 1.10.2.1 Joint dysfunction:   
    Limited joint mobility, perhaps caused by glycoslation of tissue protein, is 
a marker for long-term poor control and is associated with other 
complications (e.g. retinopathy, nephropathy and neuropathy). The hand and 
other joints should be examined.  (19) 
1.10.2.2   Growth disturbance: 
    Linear growth is negatively affected by boor diabetic control. Decreased 
growth velocity, crossing percentiles downward for height and weight, 
eventual short stature, and delayed skeletal and sexual maturation are 
associated with chronic under treatment with insulin. An extreme form of 
this, the Mauriac syndrome, or diabetic dwarfism occurs rarely and usually 
associated with hepatomegaly. Alternatively, treatment with excessive insulin 
 doses often leads to excessive weight gain, causing the weight curve to cross 
percentiles upward. (19) 
1.10.2.3 Neuropathy: 
    Symptomatic diabetic neuropathy, peripheral or autonomic, is uncommon 
in children and adolescents with IDDM, although changes in nerve 
conduction may be measured after 4-5 years of diabetes. Overall, neuropathy 
is a common IDDM complication, and its frequency increases with the 
duration of disease and degree of hyperglycemia. Improve glyceamic control 
may help neuropathic symptoms. Clinical trials of aldosereducatase inhibitors 
have reported serious side effects.  (19) 
Nephropathy and Retinopathy: Will be discussed later. 
1.10.2.4    Macrovascular complications: 
    Patients with IDDM tends to have coronary artery, cerebrovascular, and, 
and peripheral vascular disease more often at an early age, and more 
extensively than non-diabetic population. Hypertension, hyperlipidemia, 
smoking are other risk factors. (19) 
 
 
 1.11 Prevention of diabetes mellitus: 
    The United State Diabetes Prevention Trial 1(DPT1), based on the 
promising pilot data, that suggested preservation of insulin secretion and 
prevention of progression to diabetes mellitus in at risk individuals, treated 
with insulin. Daily subcutaneous insulin coupled with intensive intravenous 
insulin every 9 months prevented diabetes for at least 3 years in five subjects. 
Nicotinamide is also under study. (6) 
1.12   Prognosis: 
    IDDM is not a benign disease. In one study on the long-term outcome of 
45 children less than 12 years of age at the time of diagnosis, there were 
deaths within 10-25 years of diagnosis: three deaths were directly attributable 
to diabetes, and two deaths were due to suicide, another three patients 
attempted suicide unsuccessfully, visual, renal, neuropathic and other 
complications are relatively frequent. Furthermore, although diabetic children 
eventually attain a height within the normal adult range, puberty may be 
delayed and the final height may be less than the genetic potential. 
    The introduction of portable devices that can be programmed to provide 
continuous subcutaneous infusion of insulin with meal related pulses is one 
approach to the resolution of these long-term problems. 
     The changing pattern of metabolic control already is having a profound 
influence on reducing the incidence and severity of certain complications. For 
example, after 20 years of diabetes there is a decline in the incidence of 
nephropathy in Sweden among children diagnosed in 1971-1975 compared 
with those diagnosed in the preceding decade. Also in the majority of patients 
with microalbuminuria in whom it was possible to obtain good glyceamic 
control, microalbuminuria disappeared.  Thus, prognosis is related to 
metabolic control. (6)  
1.13 Diabetic Nephropathy:  
    Diabetes has become the most common single cause of end stage renal 
disease (ESRD) in the USA and Europe. This is due to the facts that diabetes 
(particularly type II) is increasing in prevalence, and diabetic patients now 
live longer. In the USA diabetic nephropathy accounts for about 40% of new 
cases of ESRD (20). 
    About 20-30% of diabetic patients develop evidence of nephropathy. In the 
USA, one study reported that 50% of people with childhood-onset IDDM 
develop nephropathy but only 8% develop end stage nephropathy. (21) 
    In Sweden the cumulative incidence of persistent albuminuria after 25 
years of IDDM decreased from 30% in patients whose diabetes commenced 
between 1961 and1965 to 8.9% in those whose diabetes was diagnosed 
 between 1966and 1976 , a decline attributed to better glyceamic control . The 
DCCT provided clear evidence that meticulous control significantly reduce 
the incidence of albuminuria in patients with IDDM. (22) 
    In Japan, renal disease was the cause of death in 11.9% of subjects who 
died during a 20 years follow up of 1221 diabetic patients. 
    The differing prevalence rates of nephropathy in different populations may 
be consequence of genetic factors. (23) 
    A genetic predisposition to diabetic nephropathy has been ascribed to DNA 
sequence differences in the gene for (ACE) which activates angiotesin II and 
inactivates the vasodilator bradykinin. 24) However, the relation between ACE 
and the predisposition to diabetic nephropathy is controversial. (8) 
1.13.1    Pathology: 
    Diabetic glomerulosclerosis is ordinarily divided into two forms that 
represent accelerated disease, diffuse and nodular forms. In the diffuse form, 
the entire mesoangium is thickened. The nodular form consists of capsular 
drops, fibrin caps, and adhesions in the glomeruli, micro aneurysms, and 
large spherical accumulations of PAS-positive material in the mesoangium at 
the periphery of the glomerular tuft (the glomerular nodules of Kimmelstiel 
and Wilson). (25) 
     Diabetic nephropathy begins with thickening of the glomerular basement 
membrane, an increase in mesoangial matrix (a forerunner of diffuse 
glumerusclerosis), and substantial hyaline thickening of both afferent and 
efferent arterioles. These changes begin to appear 1.5-5 years after the 
metabolic abnormality is recognized. (26, 27)  
     Normally the mesoangium takes up and processes macromolecules from 
the circulation, this capacity to clear macromolecules is impaired in diabetes. 
Accumulation of albumin and large proteins within the glomerular wall and 
in the mesoangium may stimulate mesangial matrix production and lead to 
the diffuse and nodular changes of diabetic nephropathy. (8) 
     Plasma proteins, particularly albumin, are deposited along the tubular 
basement membrane and Bowman's capsule in the kidney, and in the 
basement membranes of muscle and skin. Five years after the onset of 
diabetes, hyalinosis of the efferent glomerular arterioles and early 
Kimmelstiel-Wilson nodules may be detectable. Normal kidneys transplanted 
into diabetic recipient develop these changes within 4 years, suggesting that 
an abnormal metabolic environment is causal. (8) 
1.13.2    Natural history: 
     At the onset of diabetes, the kidneys are usually enlarged, owing to 
increased glomerular and tubular size. When the metabolic control is poor the 
 glomerular filtration rate is high. Microproteinuria (<550mg protein/24hrs, 
mainly albumin of glomerular origin) is present in sub optimally controlled 
patients and resides after 72hrs of intensive insulin treatment, although 
glomerular size remain above normal. The reversible component of 
microproteinuria is attributed to the haemodynamic abnormalities and to loss 
of charge selectivity of the glomerular membranes. (28, 29) 
     At first, microalbuminuria is present only after a provocative exercise test 
(8). However, if microproteinuria exceeds 50mg/24hr, there is a high risk of 
future macroproteinuria. Persistetant Macroproteinuria in excess of 550mg / 
24hr indicates glomerular basement membrane disease. From this point on, 
glomerular filtration usually declines inexorably by about 11ml/min/yr, and 
renal failure is inevitable. The presence of hypertension accelerates renal 
failure. (30) The nephrotic syndrome is common and diabetic retinopathy is 
almost always present in one study of 134 diabetic patients, only 28% 
survived to10 yrs after the onset of continuous protienuria. At the end, stage 
of diabetic nephropathy the kidney is reduced in size but not to the degree 
seen in end-stage glumerulonepheritis or pyelonepheritis. Most IDDM 
patients with nephropathy die not of uremia but of cardiovascular disease, 
which is 30-40 time more common than in IDDM patients without 
nephropathy. (31)  
 
 1.13.3   Treatment of diabetic nephropathy:  
     There is no specific treatment of diabetic nephropathy apart from the hope 
that meticulous control may slow its progression. Therapeutic interventions 
used to prevent progression of early nephropathy include aggressive 
treatment of glyceamia, antihypertensive therapy (particularly with ACE 
inhibitors), and a low protein diet. Early aggressive treatment may rarely 
cause microalbuminuria and increased glomerular filtration to disappear (32, 
33). Strict control can also prevent progression to macroproteinuria. 
Progressive renal disease characterized by gross protienuria, hypertension, 
and diminished glomerular filtration rate is not hoped by intensive insulin 
therapy. (8) 
1.14    Microalbuminuria: 
    In 1963, a sensitive method for detection urinary albumin in low 
concentration was described and since then many studies have performed to 
establish the rate of urinary albumin excretion (UAE) that is predictive of 
later nephropathy. (34, 35) 
1.14.1    Definition: 
     Microalbuminuria (MA) is defined as an albumin excretion rate of 30-
300mg/24hrs. (20-200microgram/min) in two out of three timed collections. 
 Timed collection may be difficult to collect in children and an alternative 
screening tool is the measurement of the albumin: creatinine ratio in a 
random spot collection. First void or other morning collections are preferable 
because of the known diurnal variation in albumin excretion. (2) 
     Persistent Microalbuminuria affects approximately 10% of children & 
adolescents. (2) 
      It was concluded from several reports that a cut-off level of 
20microgram/min would include almost 80% of patients at risk of developing 
diabetic nephropathy (36,37)Without specific interventions, 80% of subjects 
with type I diabetes who develop sustained Microalbuminuria have their 
urinary albumin excretion increase at a rate of 10-20% per year to the stage of 
overt nephropathy or clinical albuminuria (>300mg/24hr or 
>200microgram/min) over a period of 10-15 years, with hypertension also 
developing along the way.(20) The rate of albumin excretion increases quite 
dramatically during puberty, after puberty the rate may declines and MA may 
be transient in around 50% of young people with diabetes.(38) However, in 
those subjects with transient MA a rates of increase during prepubertal years 
are similar to those who have persistent MA, and although they may be 
protected during puberty by lower HbA1C levels, they are probably still 
genetically at risk of nephropathy and persistent MA may develop within 
three years in 20% of those adolescents with apparently transient MA. (38) 
      In addition to its being the earliest manifestation of diabetic nephropathy, 
albuminuria is a marker of greatly increased cardiovascular morbidity and 
mortality. Thus the finding of MAU is an indicative for screening of possible 
vascular/ disease and aggressive intervention to reduce all cardiovascular risk 
factors. (20) 
1.14.2    Risk factors of Microalbuminuria:  
1.14.2.1. Glyceamic control: 
     The risk of developing MA increase exponentially with increasing HbA1C 
above the normal level. In one cohort study, approximately 40%of 
adolescents with mean HbA1C of 10.5% or higher develop MA (transient or 
persistent) within 12years from diagnosis of IDDM. For every 1% increase in 
HbA1C there was an associated increase of 36%in the risk of developing MA. 
(38) 
1.14.2.2. Blood pressure: 
     Although hypertension is almost always associated with diabetic 
nephropathy in IDDM, elevation in routine office BP have not consistently 
been identified before onset of MA. However, one small study measured, 
24hrs ambulatory BP reported that an increase night to day ratio of arterial 
 BP night precedes the development of MA. In contrast, higher BP levels 
certainly contribute to the progression of persistent Microalbuminuria. (38) 
1.14.2.3. Family phenotype and genetic risk for developing 
Microalbuminuria in IDDM: 
     The risk of developing diabetic complications is most likely partially 
inherited. Family history of diabetic nephropathy is associated with increase 
risk of this complication in relatives with IDDM. Within families, a history of 
parental hypertension is also associated with nephropathy risk in the 
offspring, as is a history of type II diabetes in the parents. One study 
investigated parental factors in 300 young subjects and found that familial 
hypertension and cardiovascular disease were associated with MA in the 
offspring  
     The strongest association between nephropathy and APO-E 
polymorphism, which may influence lipoprotein  levels and 
acetylchoinesterase genotype which is known to be related to ACE 
expression and response to treatment with ACE inhibitors.(38) 
1.14.2.4.    Endocrine and gender difference: 
     The observation that puberty is the watershed for development of diabetic 
complications indicates that hormonal factors may be important. Risk of MA 
 during puberty is greater in females than males, even where HbA1C levels are 
similar. (38) 
     Perturbations in growth hormone/1GF-1 axis are thought to be important 
in these gender differences ,but alternate mechanism may relate to mild 
elevations in testosterone levels and the free androgen index that have being 
reported in girls with MA.(38) 
1.14.3    Intervention: 
     The diabetic control and complications trial (DCCT) showed beyond any 
doubt that reduction in HbA1C levels could prevent the development and 
progression of diabetic nephropathy. No threshold could be identified under 
which there was no risk of diabetic complications. However, considerable 
risk reduction can be achieved by lowering HbA1C by 1% or 2% in those with 
high levels. 
     In adults, reduction of blood pressure to near normal levels is also 
effective in preventing the progression of diabetic nephropathy. The use of 
ACE inhibitors is now common in adults with MA. There have been few 
studies of ACE inhibition in adolescent with type I DM, but these indicates 
that it may have similar effects in reversing MA, one study suggested it may 
prevent the morphological changes on renal biopsy specimens associated 
with progression of MA. However, ACE inhibition can be associated with 
 troublesome cough in 10% of patients, and compliance with therapy has 
never been tested in adolescent age group. Furthermore, these drugs are 
potentially teratogenic.  
     Finally, up to 30-50% of teenagers with MA may revert to 
normoalbuminuria at the end of puberty. ACE inhibitor in subjects with 
transient MA may prevent renal damage during puberty and thus alleviate 
any later nephropathy risk, but this hypothesis has never been tested in 
randomized control trial. (38) 
1.15    Retinopathy: 
     Although diabetes is a leading cause of adult blindness in the USA, the 
risk of blindness in an individual patient is low. Probably less than 10%. (39, 
40) Nevertheless, it is an ever-present fear for those with the disease. 
1.15.1 Prevalence: 
     The prevalence of diabetic retinopathy in adolescents varies from 18-47% 
& more than 90% of IDDM will eventually develop some degree of 
retinopathy. (2) 
 
 
 1.15.2    Natural history: 
     Diabetic retinopathy is usually categorized as background (simple) or 
proliferative, these forms presumably represent different stages of the same 
pathophysiology process. (8) 
1.15.2.1   Background Retinopathy:  
     Background retinopathy is present in 3% of diabetic Pina Indians diabetic  
at the time of diagnosis.(41) The prevalence increases with age, and after 25-30 
years of disease at least 90% of patients have retinal lesions.(42) 99.5% of 
IDDM patients have some type of retinopathy after 15 yrs of disease and 67% 
have proliferative retinopathy after 35yrs of  IDDM.  (43) 
     Background or simple retinopathy includes dilatation, constriction and 
tortouisty of vessels, microaneurysms, dot-shaped inner retinal hemorrhages, 
dot-bolt, linear, or flame-shaped preretinal hemorrhages, and hard or soft 
exudates. Hard exudates are caused by leakage of proteins and lipids from 
hyperpermeable capillaries and tend to form rings, often in the macular area. 
Cotton wool exudates represent micro infarctions. A sudden increase of 
cotton wool spots usually heralds a rapid progression of retinopathy, hard 
exudates may coalesce into yellow patches and impair vision if they extend 
into macular region, microaneurysms of retinal capillaries, which are thought 
to develop subsequent to loss of supporting pericytes around the capillary 
 wall are transient lasting from months to years, they frequently become 
hyalinsed and appear as whitish spots. Macular edema can lead to serious loss 
of vision. (8) 
1.15.2.2    Proliferative retinopathy: 
     Proliferative retinopathy is the most serious complication of diabetic 
ophthalmopathy, carries a high risk of vitreous hemorrhage, scarring, retinal 
detachment and blindness. (42, 44)  
     Although estimates vary widely ,up to10% of patients with IDDM develop 
proliferative retinopathy within 15 yrs and more than 25% are affected after 
20-50 yrs , blindness develop in 40% of IDDM patients  and in 60% of 
NIDDM within 5 yrs after the onset of proliferative retinopathy. Because of 
associated nephropathy and coronary artery disease, proliferative retinopathy 
indicates poor prognosis for life as well as for vision. The initiating event in 
proliferative disease is new vessels formation. The new vessels radiate out 
from the optic disk or peripheral vessels, initially on the retinal surface 
unsupported by connective tissues, and may rupture and bleed into the 
vitreoretinal space. Ultimately, they become encased in connective tissue 
forming adhesions between the Vitreal gel and retina. Traction from the 
vitreous humor cause by glial proliferation may result in either hemorrhage or 
retinal detachment. Vitreal hemorrhage itself may stimulate contraction, 
 leading to lifting of retina attached to it. Gelial proliferation from the disc 
may also occur independently of vascularisation, and if it covers the macula 
may cause blindness. (8) 
1.15.3    Pathogenesis:  
     Capillary vasodilatation and hyperpermeability, basement membrane 
thickening, loss of endothelial cells and pericytes, focal occlusion of 
capillaries, and formation of arteriovenous shunts are thought to combine 
with abnormalities in the blood to cause retinal ischemia, the presumed first 
step in the pathogenesis of retinopathy. (45) Factors lead to decreased blood 
flow in the retina, are identical to those play a role in renal disease. These 
include increased blood viscosity (46,47),red blood cell slugging and 
aggregation (48,49),increased level of fibrinogen ,and diminished fibrinlysis 
related to inhibition of plasma by increased concentration of alpha2-globulin 
(50,51,52),or increased activity of tPA inhibitor type1(53) . High levels of von 
Willerebrand factor increased production of thromboxane A2 (55, 56) by 
platelets, and reduced prostacyclin production by endothelial cells, favors 
platelets aggregation. (56, 57) Impaired release of oxygen from hemoglobin 
result from combined effect of increased HbA1C and reduce 
2,3diphosphglycerate levels, may contribute to local hypoxia. (58, 59) Increased 
vascular permeability is a very early lesion (60, osmotic stress or increased 
vesicular transport may play a role. (61, 62) Ischemia probably stimulates new 
 vessels formation. Capillary leakage may result from a dysfunctional 
endothelium caused by ACE, because blockade of the receptor ACE reverses 
vascular hyperpermeability in diabetic rats. (63)         
     The enzyme for sorbitol formation are present in the retina and support for 
a casual role of the polyol pathway in diabetic retinopathy comes from 
studies indicating that alternation of the blood-retinal barrier can be prevented 
or reversed by inhibitor of aldose reductase. (64,65) Genetic determinants may 
also be operative.(66) IDDM patients with HLA-DR4 who are negative for 
DR3 are five times more likely to develop proliferative retinopathy than those 
negative for both DR4 & DR3. (67) In one study an allele of aldose reductase 
gene was associated with early-onset retinopathy. (43) 
1.15.4    Evaluation and treatment:  
     Intravenous florescein angiography with retinal photography is the most 
sensitive procedure for diagnosis, although plain color photographs are also 
helpful. Early breakdown of the blood-retina barrier can be elevated by 
quantitative vitreous florophotometry. (68) 
     Photocoagulation with the xenon and or an argan laser is the most 
effective treatment for proliferative retinopathy. The laser destroys new 
capillary, leaky vessels, and microaneurysms can diminish retinal edema and 
reduce the incidence of hemorrhage and gliosis. Pan-retinal photocoagulation 
 is used to diminish retinal oxygen demands and preserve blood flow in 
unaffected areas. (8) 
     Pars plana vitrectomy may be required when blindness is the result of 
vitreous hemorrhage or opacification provided serious proliferative 
retinopathy not present. (60, 50, 69) 
     In 1993 Dr Elamin A, Ibrahim M, Ismail B, studied 51Sudanese child with 
IDDM 9-18 yrs old, for Microalbuminuria. They showed a prevalence of 
25.5% of MAU, and the prevalence increase to 42% in the age group 13-
18yrs. Two patients with microalbuminuric were 10 and 12yrs old and both 
had diabetes of less than five years duration. The AER correlated with 
chronological age and duration of disease. The effect of age on AER was 
significant even when the influence of duration of diabetes was eliminated. 
No gender differences was shown, both systolic and diastolic arterial blood 
pressure values were significantly elevated in microalbuminuric patients. 
HbA1c and insulin dose U/Kg/ day were significantly higher in 
microalbuminuric and no difference was seen in fasting plasma glucose or 
cholesterol levels. The prevalence of DR (funduscopy) was significantly 
greater (P<0.01) in Microalbuminuric (23%) than in non-Microalbuminuric 
ones (8%), and heights of Microalbuminuric tended to be lower than heights 
of diabetic patients matched for age and sex with normoalbuminuria. (34) 
      Dr Osman W ,in 1994 studied 86 Sudanese diabetic patients with both 
IDDM and NIDDM with duration more than 5 years showed a prevalence of 
MA been 31.3%,and showed that female gender, original home from central 
Sudan ,family history of renal disease, duration of DM,HbA1c, high blood 
pressure were the risk factors. Lipid profile and cigarette smoking did not 
correlate to MAU. She also found that, retinopathy and peripheral neuropathy 
were found in almost all cases with MAU. Whereas macroangiopathy were 
not. Blood urea and serum creatinine were normal in patients with MAU. (70) 
    In  2001 April at Tahar Sfar hospital Tunisia, a study of 36 diabetic child 
with duration more than 5 years, showed that 44% of patients had diabetic 
retinopathy (using florescein angiography). Background retinopathy was 
found in 31%, preproliferative retinopathy in 5% and proliferative in 8% of 
cases and it was found to be associated with diabetic maculopathy in 8 
patients and cataract in 4 patients. DR was correlated with age of patients at 
diagnosis of DM, sex, duration and balance of diabetes. And concluded that 
the frequency of DR increased with the duration and the imbalance of 
diabetes. And recommend that the regular ophthalmologic examination as 
well as balanced diabetes were necessary to decrease the frequency of DR(71). 
    EL-Asrar AM , et al from King Saud University -Riyadh –College of 
medicine in 2001 studied the predictive value of retinopathy for the presence 
of other diabetic complications, in 648 patients with DM of them, 
 210(32.4%) with IDDM, and 438(67.6%) with NIDDM. The study showed 
that the association between retinopathy severity levels and the prevalence 
rate of nephropathy were significant in the total group (P=0.0001). In patients 
with mild-moderate, nonproliferative retinopathy (NPDR) nephropathy was 
present in 17.2% of patients with IDDM and in 11.4% of patients with 
NIDDM. In patients with sever NPDR, nephropathy was present in17.2% of 
patients with IDDM, and in 11.4% of patients with NIDDM. In patients with 
sever NPDR nephropathy was present in 23.3 in pts with IDDM and in 11.8 
of NIDDM. In pts with PDR nephropathy was present in 50 % of IDDM, and 
in 45.5%of NIDDM, and concluded that retinopathy, especially the presence 
of PDR is an independent predictor for nephropathy. The predictive value of 
retinopathy for nephropathy was stronger in patients with IDDM than those 
with NIDDM. (72) 
In a nation-wide cross-sectional study of retinopathy and microalbuminuria in 
371 young Norwegian IDDM patients on November 1992,with age range of 
8-30.3 years and duration range of  (6.2-17.3), retinopathy was found in 
32.8% (7.3% of them less than 13 yrs) the youngest patient with DR was 9.6 
yrs old. MA was found in 12.5% and 2.4% of patients aged less than 13yrs. 
The youngest subject with MA was 11.5 yrs old. Patients with DR had 
significantly higher mean age (P=0.0001), longer mean duration of diabetes 
(P=0.0001) compared to patients without DR. In patients with MA HbA1C 
 and mean arterial blood pressure were significant higher compared to non-
microalbuminuric, but there was no difference in age or diabetic duration. 
With multiple logistic regression model ,age ,HbA1c,duration of DM and 
mean arterial BP ,were found to be significantly associated with retinopathy 
,while HbA1c, mean arterial BP ,onset before 13.4 years of age ,were found to 
be associated with MA. (73) 
  In a study conducted by, Salardi S, et al, from Bologna University –Italy 
2001 In 127 IDDM children at their 0-15month duration of DM, 14 pts (11%) 
showed readable angiographies with minimal retinal changes, and concluded 
that the presence of early lesions in the first year of the disease in 11% of the 
patients was probably due to the method of examination (florescein 
angiography), which may detect even minimal retinal changes. (74) 
     A study, done in May 2004 by the Danish Study Group of Diabetes in 
Childhood in a prospective cohort of 339 child and adolescent with type 1 
DM. The patients were followed for 8 years to study the effect of the 
prepubertal duration of diabetes on early retinopathy and elevated albumin 
excretion rate, among them 304 had a prepubertal onset of DM(onset<11.7yrs 
in girls and 12.9 yrs in boys). It revealed that the prevalence of retinopathy 
was 17.7% in age group 12-15 yrs, 45.4% in 16-20yrs, and increased to 
67.6% in patients more than 20 yrs of age. And there was association with 
HbA1C and diabetic duration both in patients with prepubertal and pubertal 
 onset of DM, non of the patients younger than 15 yrs of age had elevated 
AER. While AER was about 14% from 15 yrs of age and onwards. AER was 
significantly related to HbA1C but was not correlated to diabetic duration 
neither before nor after the age of 12yrs.  (75) 
     In1999, Olsen B S, et al, from University hospital of Gostwip, Denmark , 
studied 339 patients with median age 21.1(12-26.9) and median diabetic 
duration 13.2 (8.9-24.5) for HbA1C, overnight albumin excretion rate(AER), 
they revealed that HbA1C was 9.71 ± 1.7% (mean ± SD), males had higher 
HbA1C values than females. Mean daily insulin dose was 0.92 ± 0.25 
IU/kg./24hr. Microalbuminuria (AER) and macroalbuminuria were found in 
9% and 3.7% of the patients respectively and was associated with increased 
diastolic blood pressure and presence of retinopathy. Retinopathy was present 
in approximately 60%of patients and was associated with age, diabetes 
duration, HbA1C, diastolic blood pressure and AER.  (76) 
     In 2000, Campos-Pastor M M, et al, from Hospital clinico, Spain studied 
the prevalence of Microalbuminuria in 312 patients with type 1 DM over 6 
months. They detected a prevalence of 29% of MA, and realized that the 
prevalence of MA was high during second decade of diabetes and declined 
there after and showed that dyslipidaemia, previously diagnosed 
hypertension, family history of diabetic nephropathy, and laser treated 
 retinopathy to be factors associated with the presence of MA and revealed an 
association between MA and family history of nephropathy. (77) 
     In 2004, Svesson M, et al, from Umea University –Sweden, studied the 
impact of glyceamic control (HbA1C) early in the disease and age at onset on 
the occurrence of incipient diabetic nephropathy (MA) and background 
retinopathy (RP) in childhood onset diabetes type1, a 94 patients were 
retrieved from medical records (since1992), it was found that 18% developed 
MA and 48% developed RP and 52% had either or both complications. And 
HbA1C during the follow up was significantly associated with both MA & RP 
when adjusted for sex, birth weight, age at onset and tobacco use as potential 
confounders. Mean HbA1C during the first five years of diabetes was a near- 
significant determinant for development of MA and significant determinant 
of RP. The age at onset of diabetes significantly influenced the risk of 
developing RP (1.11, p=0.021).  (78)              
     Porta N ,et al , from University of Turin- Italy , in2004,June, conducted a 
study to verify the influence of pre-pubertal diabetes in the development of 
retinopathy  in 628 patients (pre-pubertal age defined as 0-12 in males and 0-
11 in females ), 200 patients of who developed diabetes before puberty and 
428 after puberty screened with ophthalmoscopy+35mm photography or 
digital photography, and showed that a prevalence of retinopathy was lower 
among patients with prepubertal onset and diabetes duration 10-14 and 15-
 19yrs (p=0.006 and p=0.003,respectively), but prevalence rates became 
similar after 20 yrs duration , and concluded that retinopathy was infrequent 
and mild during childhood ,  probably due to the short duration of diabetes 
rather than a specific protective effect of pre-puberty. And after 20 yrs 
duration however, the prevalence of retinopathy was no longer influenced by 
age at onset suggesting that in the longer term, prepubertal years do 
contribute to the onset of retinopathy. (79)  
     Viss Study Group in university hospital- Linkooping -Sweden, at 2002, in 
390 patients, fundus photographs were evaluated and revealed that in 71% no 
retinopathy was seen and prevalence of retinopathy was increased from 11% 
among patients 5 yrs old at diabetes onset to 48% among those 15-19 yrs old 
at diabetes onset and then decreased to 30% for patients 30-35 yrs old at 
diabetes onset, it was concluded that in patients with diabetes duration of 6-
13 yrs the prevalence of retinopathy is clearly related to glyceamic control. 
Furthermore, the risk of retinopathy varied with different age at onset, and 
was independently varied with differences in duration or glyceamic control. 
(80) 
     A study of insulin dependant diabetics in Craiova, included in the 
selective screening programs, for evaluating the incidence of diabetic 
retinopathy, at 2003, in a retrospective study of 156 patients revealed the 
incidence of diabetic retinopathy was 35.2% at the time of implementing of 
the screening program, being 50.2% after 5 yrs of continuous surveillance 
 follow up of patients with IDDM. The incidence of new cases was minimal in 
age group 0-10yrs (1.9%) and retinopathy was absent. (81) 
     In Australia (Westmead) at 2003, 193 adolescents, were followed 
longitudinally for retinopathy (early background) and microalbuminuria, to 
compare the effect of pre and post pubertal diabetes duration on the risk of 
each complication, it revealed that prepubertal duration improve the 
prediction for retinopathy over post prepubertal duration alone in the young 
adults and the time to onset of all complications increased progressively with 
longer diabetes duration before gonadarche. Also, conclude that higher 
HbA1c during adolescence had an independent effect on the risk of 
retinopathy, and microalbuminuria was nonuniform with an increase delay in 
the onset of complications in those with longer prepubertal duration. (82)   
 
 
 
 
 
 
 Justification 
•  Early identification of retinopathy and nephropathy in IDDM, 
offers a better chance for successful intervention. 
•  No similar study was done in Sudan except a limited study 
in1993. 
 
 
 
 
 
 
 
 
 
 
 
 0bjectives 
 
1. To determine the prevalence of microalbuminuria, and retinopathy 
among adolescents with IDDM. 
2. To identify the effect of age, sex, pubertal stage, duration of diabetes, 
glyceamic control, Hypertension, and Family history of DM, 
hypertension, diabetic nephropathy and retinopathy, on the 
development of diabetic retinopathy and microalbuminuria. 
  
 
 
 Chapter Two 
Material and methods 
 
2.1    Study design:- 
 A Cross-sectional hospital based study. 
2.2   Study area:  
     The study was conducted in Khartoum state in three main diabetic referral 
clinics of Ahmed Gasim Hospital, Gafar Ibnof Hospital and Jabir Aboeleiz 
centre. 
2.3  Study duration; 
     The data was collected within four months from September to December 
2004  
2.4   Study population: 
    Adolescents age 9~18 years with IDDM. 
2.5    Sample size: 
    The statistical form used to calculate the sample size was: 
 
 
 
 n =    N2ZPQ 
    d2(N-1) +Z2PQ 
N =     Population frame.  
n =     Sample size. 
P =    Prevalence. 
Q =    1-p. 
Z =    1.96. 
d =    desired margin of error.   
    86 patients aged 9-18 yrs fulfilling the inclusion criteria on the study area 
were enrolled in this study. 
2.6    Inclusion criteria: 
    All patients with diabetes mellitus aged 9-18 yrs and using insulin were 
included in this study. 
2.7   Exclusion criteria: 
- Patients less than 9 yrs old. 
- Patients with UTI, ketosis or other renal disease. 
- Patients with NIDDM or sickle cell disease. 
2.8   Study tools: 
1. Questionnaire. 
2. Physical examination. 
 3. Ophthalmic fundus examination. 
4. Lab investigation. 
2.9   Study technique: 
    Consent was obtained from all parents and children included in this study.  A 
questionnaire containing personal history, duration of diabetes mellitus, number 
of DKA and hospital admissions in the last year  , doses of insulin per day, 
compliance to management and family history of DM, diabetic nephropathy, 
diabetic retinopathy and hypertension. 
    Growth parameters according to the NCHS were plotted to all participants. 
Arterial blood pressure was measured in the setting position using appropriate 
cuffs and NHLBI charts. 
    Sexual maturity rate was assessed according to Tanner JM courtesy. Joints 
were examined for the presence of joint immobility. Cardiovascular system was 
examined clinically for evidence of cardiomegaly or heart failure. 
    Fundus was examined to 48 pts of the participatants (those who came to the 
eye clinic) by an expert ophthalmologist using professional ophthalmoscope. 
    Fresh urine sample was taken from all the participants in sterile containers. 
Half of it tested for sugar, proteins, ketones , nitrite , leukocytes and RBCs using 
 (CYBOWTM) reagent strips for urinalysis(detect 50mg glucose /dl, trace ketones 
,10-15 mg/dl protein , 105 /ml nitrite , 20-25 WBC/Ul ) , the other half 
measured for albumin /creatinine ratio .All patients with elevated ratio have 
another overnight timed collection (before going to bed the participant passed 
urine and record the time . the urine passed shortly after he got up in the 
morning was then collected in sterile plastic bottles and the time was noted .Any 
urine passed during the night was also collected in the same bottle ) for albumin 
excretion rate . 
    The albumin content of the urine was measured by latex agglutination and 
turbidimetry (sensitivity 6.2mA.L/mg,detect 0.9mg/l). (83) And creatinine was 
measured by Picrate in alkaline media (detect 0.03 mg /dl, sensitivity 31 Ma. Dl 
=0.351mA.l/umol). (84) 
    A one ml of whole blood was taken from patients in EDITA containers and 
measured by ion exchange and photometry (sensitivity <4.3 %) for HbA1c. (85) 
2.10   Case definitions and severity:  
    Diabetes mellitus is diagnosed in the presence of fasting blood glucose 
concentration of >7 mmol/l or RBG of>11.1mmol/l or a documented diabetic 
GTT curve. 
      IDDM is referred to all cases of diabetes in which exogenous insulin is 
required to prevent ketoacidosis regardless to etiologic causes. Urine is 
considered positive for microalbuminuria when albumin /creatinine ratio 
between 30-299 ug alb/ mg creatinine in spot collection or 15-150 ug alb /min in 
overnight collection.  
    HbA1c indicated good glyceamic control when rage between 6.7-7.3%, fair 
control between 7.3-9.1, and bad control when >9.1.  
    Background retinopathy considered present when fundus showed 
microaneurysms, hemorrhages or exudates (soft or hard).And, 
    Proliferative retinopathy considered present when new vessels, scars. Vitreal 
hemorrhages .or retinal detachment showed in fundus examination confirmed by 
an ophthalmologist   
2.11   Statistical analysis: 
    Statistical analysis was performed by SPSS Computer program. Pearson chi –
square, Yate’s correction, and Fisher’s Exact tests were used when indicated.  
 
 
 
 Chapter Three 
Results 
    A/C ratio was done to the all 86 participant included in the study, with a mean 
age of 13.6±2.6 years (mean±SD), and mean duration of 4.4±3.4 years. 
Overnight urine sample was collected by 54 patients (62.8%)  (Those who tested 
+ve for A/C ratio). 
      All participating children tested negative with CYBOW TM reagent strips for 
urinalysis. The fundus was examined for 48 participatants &38 patients did not 
report for expert ophthalmology testing.  
  3.1 Age and gender distribution of IDDM adolescents: 
    86 insulin dependent diabetic adolescents were involved in this study. 41 
males (47.7%) and 45females (52.3%). Male to female ratio was 1:1.1 with 
slight female preponderance Fig (1). 
    The study group was 9–18 years of age Fig (2). 20.9% were 15-18years age 
group, the majority was 12-15yrs old. 
 
\ 
 
 
 3.2 Distribution of IDDM adolescents according to tribes and region of 
origin: 
   The Arabic tribes almost constitute two thirds of the study population. African 
tribes and non-Sudanese origin compose 3.5% each. Ethiopia and Yemen were 
the origin of the three participatants of the non-Sudanese origin Table (1). 
   The majority of the IDDM patients were originally from the central region of 
Sudan. 19.8% were from the western region and only 3.5% were from the 
southern region. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig (1):Gender distribution in IDDM adolescents (n =86)
Male, 48%
Female, 52%
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Fig(2) :Age distribution in IDDM adolescents.  (n=86)
 
  
 
 
Table1: Tribal origin of diabetic adolescents 
 
 
 
  Variable                                     No                                                    %  
 
Arabic tribes                                  57                                                   66.3                                 
   
Nubian tribes                                 09                                                   10.5                       
 
Afro Arabs tribe                            14                                                   16.3 
  
African tribes                                03                                                   03.5 
 
Non Sudanese                               03                                                   03.5 
 
Total                                             86                                                    100 
 
 3.3 The level of education and the effect of diabetes mellitus on the 
school performance and attendance: 
   4.75% of the IDDM participatants were not educated. Two were university 
students and the majority was at basic level (64%).Fig (3) 
   Although 73.2% had regular attendance, when considering school 
performance after developing DM, 37 diabetic patients deteriorated and only 
five improved their performance. In 50%, performance did not affected by the 
disease. 
  9.8% of the study group stopped their education after they develop diabetes. 
3.4 Duration of diabetes in the study group: 
   49 (57%) diabetic patients had the disease for less than 5 years duration, 16 of 
them had diabetes for less than one year, while seven (8.1%) had the disease for 
more than 9 years. Fig (4). 
3.5 Frequency of DKA episodes and hospital admission in the last 
year in IDDM adolescents: 
  40.7% of patients did not have DKA episodes last year, 27.9% were not 
admitted to hospital. Two patients (2.3%) experienced DKA and five were 
admitted to the hospital more than five times during the last year. Table (2). 
 3.6 Frequency of family history of diabetes mellitus, hypertension, 
diabetic nephropathy and diabetic retinopathy:       
  The majority (58.1%) of diabetic patients have 1st degree family history of DM, 
while two (2.3%) have 2nd degree family history of DM. The majority (55.8%) 
had neither family history of hypertension, diabetic nephropathy (94.2%), nor 
diabetic retinopathy (83.5%). Table (3) 
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Fig(3): Educational level of diabetic adolescents.  (n=86)
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Fig(4): Duration of diabetes in IDDM adolescents.(n=86)
  
 
Table 2: No of DKA episodes and hospital admission in the last 
year of IDDM adolescents 
    
          Frequency            No of DKA episodes (%)               No of hospital admissions (%) 
 
          Non                            35 (40.7)                                               24 (27.9)                                     
  
            <3                            38(44.2)                                                 39(45.3) 
 
           3 -5                            11(12.8)                                                18 (20.9) 
 
            >5                            02(02.3)                                                 0 5 (05.8) 
 
 
          Total                         86 (100)                                                   86 (100) 
 
Table 3: Family history of DM, DR, HT, and DN in IDDM 
adolescents 
 
            Variable      DM                 HT                     DN                              DR 
 
   Relation              No (%)               No (%)             No (%)                       No (%) 
 
 
+ve 1st degree        50 (58.1)              30 (34.4)              04 (4.7)                     13 (15.1) 
+ve 2nd degree     02    (02.3)               08 (9.3)               01 (1.2)                      01 (01.2) 
 
-ve                        34   (39.5)               48 (55.8)            81 (94.2)                     71 (83.5) 
 
Total                    86   (100)                 86 (100)             86   (100)                      86 (100) 
 
 3.7   Management of DM in adolescents (insulin and diet): 
   The majority (84.9%) of IDDM adolescents who participated in this study are 
on twice dose system and no participant is using more than two doses per day. 
   The mean dose used by the participants was 0.85± 0.3. None of the participant 
had more than 2 IU insulin /kg/day. More than 60% taking 0.5-1 u/kg/day and 
11.6% had <0.5u/kg/day. Fig (5). 
   Only two-thirds (67.4%) of IDDM adolescents complied with their dose of 
insulin. The frequency of non-compliance was found to be 32.6%. Fig (6). 
   Financial inability was found to be the most frequent cause of non-
compliance. Many (32.2%) were not adherent to their dose because of ignorance 
of the child and/or his family. Considerable number of the patients (17.9%) 
sometimes refused to take their doses most probably due to the difficult mood 
associated with puberty. In one participant, insulin was not available in the area 
where he resides. Table (4). 
   Most of the study group were adherent to their diet. Fig (7). 
3.8 Weights and heights distribution percentiles of children with current 
IDDM:  
The majority of diabetic patients showed poor growth matched to chronological 
age that 69.8% were less than 25th centile for weight and 55.8% for height. 
Only one participant was overweighed (>90th percentile). Table (5). 
 3.9 Sexual maturity of children with current IDDM:      
Most diabetic children showed preadolescent stage of Tanner SMR. 30.2% 
showed stage 5 SMR. Table (6). 
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Fig(5):Insulin dose per day of IDDM adolescents. (n=86)
 Fig(6): Compliance with insulin inIDDM adolescents. (n=86)
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 Fig(7): Compliance with died in IDDM adolescents.  (n=86)
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fair, 54%
 Table 4: Causes of non compliance in IDDM adolescents 
 
  
 
       Causes                                                     No                                                    % 
 
        Financial                                                   13                                                  46.4 
 
        Ignorance                                                  09                                                  32.2 
 
        Refused by child                                      05                                                   17.9 
          
        Others                                                      01                                                   03.6 
           
          Total                                                      86                                                    100 
 
 
 
 
 
 
 
 
  
Table 5:  Percentiles of weights and heights of IDDM adolescents 
 
 
Centile                                       WT                                                        HT 
                                                  No   (%)                                           No   (%) 
 
<25th centile                              60 (69.8)                                           48 (55.8) 
 
25 -75 centile                            20 (23.3)                                           25 (29.1) 
 
75 -90 centile                            05 (5.8)                                             09 (10.9) 
 
>90th centile                              01 (1.1)                                             00 (000) 
 
Total                                         86(100)                                             86 (100) 
 
 
 
 
 
 
 
 Table6: Pubertal stage of IDDM adolescents. 
 
 
             SMR (Tanner’s)                            No                                                      %             
 
              Stage 1                                              30                                                     34.9 
 
              Stage 2                                              09                                                      10.5 
 
               Stage3                                              08                                                        9.3 
 
               Stage 4                                             13                                                      15.1 
 
                Stage 5                                            26                                                      30.2 
 
               Total                                                86                                                       100 
 
 
 
 
 
 
 
 3.10 Blood pressure distribution percentiles of IDDM adolescents: 
Diabetic patients tend to have higher arterial blood pressure than non -diabetics 
that 12(14%) and 22(25.6%) had ≥90 percentiles for systolic and diastolic 
components respectively. Table (7). 
3.11 Glyceamic control (HbA1c) in IDDM adolescents: 
51.2% of the IDDM adolescents had poor glyceamic control (>9.1% HbA1c), 
only 17.4% have good glyceamic control (HbA1c <7.1%). Fig (8). 
3.12 Frequencies of long-term diabetes complications in children 
and adolescents with IDDM:  
3.12.1 Frequency of CVS complications:  
None of the diabetic patients showed cardiomegaly or heart failure. 
3.12.2 Frequency of Joint immobility:  
26.7% of the study group showed stiff joints. 
3.12.3 Frequency of cataract:  
None of the diabetic patients showed mature cataract, although two (4.2%) 
showed immature cataract by the professional ophthalmoscope. 
3.13. Diabetic retinopathy in IDDM adolescents:  
3.13.1. Prevalence: 
Prevalence of diabetic retinopathy was found to be 6.3%.  
 None of the participant showed proliferative retinopathy. Fig (9) 
3.13.2 The influence of sex on the development of diabetic retinopathy: 
    Although all the patients with background retinopathy were females, there 
was no statistical significance association found Table (8). 
3.13.3 The effect of age on the development of diabetic retinopathy: 
Two (66.6%) patients with background retinopathy were >15 years of age and 
the youngest one was 15years old Table (9). 
Fisher's Exact test was found to be near significant with age (P=0.086). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table7: Blood pressure Centiles of IDDM adolescents. 
 
 
 
 Variable centile                    Systolic                                            Diastolic 
                                 
                                            No             (%)                                     No         (%) 
 
  <75th centile                     68             (79.1)                                    53          (61.6) 
 
   75 -90th centile                06              (07.0)                                   11           (12.8) 
 
   ≥90th centile                    12              (14.0)                                   22           (25.6) 
    
    Total                              86              (100)                                    86            (100) 
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Fig(8): Diabetic control HbA1c of IDDM adolescents.(n=86)
  
 
 
Fig(9): Frequency of retinopathy in IDDM adolescents. (n=48)
Background 
retinopathy, 6%
Normal, 94%
 Table 8: The influence of sex on diabetic Retinopathy in IDDM adolescents  
 
 
Fundus Examination                                           sex                                                   
 
                                                                 Male                                        female 
 
Variable  
 
 
Normal (%within sex)               21(100)                        24(88.9) 
 
Background RP (%within sex)               00(000)                                   03(11.1) 
 
 
 
 
P=0.115 
 
 
 
 
 Table 9: The effect of age on diabetic Retinopathy in IDDM adolescents.  
 
 
 
Fundus Examination                                                  Age group                                   Total  
 
                                                                         9-15yrs               >15yrs 
 Variable  
 
 
Normal (%within age group)                     38(97.4)         7(77.8)              45(93.8) 
Background RP (%within age group)         01(2.6)          2(22.2)             3(6.4) 
 
P=0.086 
 
 
 
 
 
 
 
 3.13.4 The effect of duration on the development of diabetic retinopathy: 
All cases with background retinopathy were found to have more than nine years 
duration, the prevalence increased to 60% in>9 yrs duration. Fig (10) 
The Fisher's Exact test was found to be significant (P= 0.001), so diabetic 
retinopathy is positively correlated with the duration of diabetes. 
3.13.5. The effect of glyceamic control on the development of diabetic 
retinopathy: 
Fig (11) illustrate that the cases of background retinopathy distributed equally in 
the three groups of HbA1c. 
Statistically Yate's correction revealed no significant association between 
diabetic retinopathy and the glyceamic control. 
3.13.6   The influence of arterial blood pressure on the development of 
diabetic retinopathy: 
66.6% of the patients with diabetic retinopathy had both systolic and diastolic 
arterial blood pressure ≥ 90 percentile. 
There was no statistical significance found between diastolic BP and the 
development of diabetic retinopathy (P=0.259), but there was near significance 
with systolic component (P=0.068). 
 
 3.13.7 The effect of pubertal stage on the development of diabetic 
retinopathy: 
All diabetic patients with background retinopathy changes were found to had 
stage 5 of the Tanner SMR. 
Statistically there is significant correlation between pubertal stage and the 
development of diabetic retinopathy (P= 0.026). 
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Fig(10): The effect of duration on the development of diabetic retinopathy in IDDM 
adolescents. (n=48)
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 3.13.8 Influence of family history of DM, Hypertension and diabetic 
retinopathy in the development of diabetic retinopathy: 
 All patients with background retinopathy had family histories of both diabetes 
mellitus and hypertension but there was no statistical significant association 
found by the Fisher's Exact test. And 33% of them found to have +ve family 
history of diabetic retinopathy there was no statistical significance association 
found. 
3.13.9 Joint mobility in relation to diabetic retinopathy: 
 All patients with diabetic retinopathy found to have joint immobility. 
Statistically there is strong correlation with joint immobility (P=0.008). 
3.14 MAU in IDDM adolescents: 
3.14 .1 Prevalence: 
Prevalence of persistent MAU was found to be (38.9%). And the frequency of 
transient MAU was found to be 24.4%, 37.2% were normoalbuminuria. 
3.14.2 The influence of age on the development of MAU: 
Table (11) showed that the frequency of MAU tended to increase with age given 
a prevalence of 50% on the age group 15- 18 years old. 
Statistically there was no significant correlation with age. 
 
 
 3.14.3. The influence of sex on the development of MAU: 
Females were showed slightly more frequency (42.2%) to develop MAU than 
males do (34.1%).Table (12) 
Statistically there was no significant correlation with gender differences. 
3.14.4. The influence of duration DM on the development of MAU: 
Tow microalbuminuric patients (6.1%) had DM for less than one year. 71.4% of 
those with >9 years were microalbuminuric. Table (13) 
Yate's correction showed that duration of DM is not a confounder to MAU.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 10: Frequency of microalbuminuria in IDDM adolescents  
 
              
            Variable                                                 No                                                       % 
 
                Transient                                            21                                                        24.4 
 
                Persistent                                           33                                                         38.4 
 
                Normal                                               32                                                         37.2 
                  
                Total                                                  86                                                          100 
 
 
 
 
 
 
 
 
 
 
 
  
 
Table11: The influence of age group on MAU .on IDDM adolescents. 
 
 
     
Variable                                                                            Age in years 
 
                                                                          9 -12                       13 – 15                 >15 
 
    Normal (% within age group)                     21 (67.7%)              32 (62.2%)          9 (50%) 
      
 
    MAU (%within age group)                           10 (32.3%)              14 (37.8%)        9(50%) 
 
 
 
P =0.467 
 
 
 
 
 
  
Table12: The influence of sex on MAU in IDDM adolescents  
 
 
 Variable MAU                                              sex                                                    Total   
 
Male                               Female 
 
 
  Normal (%within sex)          27 (65.9%)                       26 (57.8%)                    53 (61.6%)                             
 
 
  MAU (within sex)                 14 (34.1%)                        19 (42.2%)                   33 (38.4%)                              
 
   
     
P =0.467 
 
 
 
 
 
 Table 13: The influence of duration on MAU in IDDM adolescents  
 
 
 
 
  Variable                                            Duration in years                                                 Total  
 
                                            <1yr               1-5yrs            5-9yrs          >9yrs 
 
 
Normal (% within duration)    14(87.5%)       21(63.6%)     16(53.35)    2(28.6%)    53(61.6%)   
 
 
MAU (% within duration)      02(12.5%)      12(36.4%)     14(46.7%)    5(71.45)     33(38.4%) 
 
x2 by Yate's =0.694 smaller than tabulated 3 df  
 
 
 
 
 
 
 3.14.5. The effect of glyceamic control on the development of MAU: 
69.7% of microalbuminuric patients have poor glyceamic control (HbA1c 
>9.1%). 30.3% had good to fair control. Table (14) 
Statistically Fisher’s Exact test showed significant correlation between MAU 
and HbA1c (p = 0.007). 
3.14.6 MAU in relation to diabetic retinopathy: 
Two out of the three diabetics with background retinopathy, were 
microalbuminuric. Table (15) 
Statistically there was no correlation between MAU & DRP. 
3.14.7. The influence of family history of DM, hypertension & diabetic 
nephropathy on the development of MAU: 
69.7%of diabetic patients with MAU had a +ve family history of DM. 48.5% 
had +ve family history of hypertension, 9.1% had +ve family history of DNP. 
MAU correlated positively with family history of DM (P=0.012). 
3.14.8. The influence of arterial BP on the development of MAU: 
18.2% of microalbuminuric patients had elevated diastolic BP. 
Statistically there were no significant correlations with neither systolic nor 
diastolic arterial BP. 
 
 
 3.14.9. The influence of pubertal stage on the development of MAU: 
Microalbuminuric patients showed different stages of SMR without any regular 
relation. 
Statistically MAU is independently affected with pubertal stage.    
 
 
 Table 14:  The effect of glyceamic control on MAU in IDDM adolescents  
 
 
 
       Variable                                                        HbA1c in %                                      Total  
 
                                                                   <9.2                      ≥9.2                                       
 
 
       Normal (%within HbA1C)            33 (76.7%)              20(46.5%)                   53(61.6%) 
         
 
       MAU (% within HbA1c)              10 (23.3%)               23(53.5%)                    33(38.4%) 
         
 
 
P=0.007 
 
 
 
 
 
 
 Table 15: MAU in relation to diabetic retinopathy in IDDM adolescents  
  
___________________________________________________________________________ 
Variable MAU                               Fundus Examination                                             Total 
 
                                                      Normal                            Background                                 
 
Normal (% within DR)                    22(48.9)                          01 (33.3)                       23 (47.9) 
 
MAU (% within DR)                       23(51.1)                          02 (66.7)                        25 (52.1) 
 
 
Total                                               45(100)                           03 (100)                           48 (100) 
 
P= 1.000 
 
 
 
 
 
 
 
 
 Table 16: The influence of systolic BP on MAU in IDDM adolescents  
 
 
 Variable MAU                                         BP in percentile                                      Total 
 
                                                             <90                               ≥90 
 
Normal (% within systolic BP)         47(63.5)                    0 6(50.0)                     53(61.6%) 
 
MAU (%within systolic BP)           27(36.5)                       06(50.0)                    33(38.4%)               
 
 
P= 0.524 
 
 
 
 
 
 
 
 
 
 
 Table17: The effect of diastolic blood pressure on MAU in IDDM adolescents  
. 
 
Variable MAU 
                                                         BP in percentile                                                      Total 
 
                                                           <90 percentile                ≥90 percentile   
 
Normal (%within diastolic BP)           39(60.9%)              14(63.6%)                  53(61.6%) 
 
  
MAU (%within Diastolic BP)             25(39.1%)                   8(36.4%)                   33(38.4%) 
 
 
 
P=1.000 
 
 
 
 
 
 
 
 Chapter Four 
Discussion 
 
    Albumin /creatinine ratio and overnight urine collections was chosen because 
it is easy to be collected in the former and the later allows a reasonable time 
period for collection and avoidance of the effect of posture and exercise on the 
albumin excretion. 
    Elevated overnight MAU have been shown to be strongly predictive of 
subsequent development of diabetic nephropathy (86). 
 
4. 1   Gender preponderance: 
The present study revealed slight females preponderance M/F ratio of 1:1.1 ,this 
result was also obtained by Elamin A , on  the studying the prevalence of 
diabetes in school age children and Abu Samra’s, on studying  children with 
DKA , as well as that reported by Salman H , et al, in Saudi Arabia who reported 
M/F=1:1.2 (11, 87, 88). 
   However male preponderance was reported  in the literature as well as in local 
studies ,that  Elkhier K , reported (M/F=1.6 :1) , Zaki M, reported (M/F= 1.3:1) 
 and Mohammed H, reported ( M/F= 1.1:1), and Abdullah M A , in Riyadh, 
Weber B, in U K ,also showed slight male preponderance (17, 16 , 89, 90 , 91). 
   These differences in sex preponderance most likely resulted from a chance 
factor that operating in sample selection as sometimes male adolescents refuses 
to participate in such studies .   
 
4. 2 Ethnic groups and original regional area: 
   The present study revealed that most of diabetic patients were originating from 
Arabic tribes (66.7%) and central region of Sudan (58.1%), similar results were 
revealed by Zaki M where the Arabic tribes constitute (83%) of her study 
population and most of them (58.5%) were from northern Sudan, southern 
regions of Sudan were not represented in her study, as they represent 3.5% in 
our series (16). 
    These findings reflect the recent migration of northern and southern 
population towards Khartoum and the central regions around it.   
4. 3 School attendance and performance: 
    Regarding schooling of diabetic children, it was found that 73.2% had regular 
attendance. 9.8% stopped their education after they developed diabetes and 
4.7% not educated at all .17.8% had irregular attendance, and 43% had 
deteriorated performance. 
    Similarly Abu Samra reported, that 89.7% had regular attendance and in 
contrast Mohammed H reported that only 41% had regular school attendance 
and 7% not educated, 14% stopped education after developed diabetes and 38% 
deteriorate in school performance, and Daod O who showed that 16.7% stopped 
education after developing diabetes, 1.9% not educated and 27.5% were 
deteriorated in their performance (87, 89, 92)). 
  These differences were explained by the differences in the age groups of each 
study, that the present study takes 9-18 years where Mohammed H and Daod O 
take 6-18years and 0-15years respectively. 
4. 4. Insulin dose, compliance and storage: 
     This study showed that 91.9% had adequate storage of insulin .15.2% used a 
single dose per day, 84.9% used two doses per day, and none used more than 
two. <0.5u insulin /kg/day used by 11.6%. The majority using 0.5-1u/kg/day, 
none of the participants used >2u/kg/day, and 67.4% were complied with their 
dose. The most frequent cause of non-compliance to insulin was the financial 
causes (46.4%), then ignorance (32.1%) and refuse to take the dose 17.9%.  
    These results were similar to those reported by Abu Samara in which 2/3 of 
her study population used two doses per day and 35.8% used single dose, none 
used more than two doses and Mohammed's H where 70% used twice, 26% used 
once and 4% used more than two doses per day. And these results were unlike 
 those reported by Zaki and Daod where 56.9% and 91.2% take single dose 
respectively. These differences reflect the tendency towards using multiple 
doses regimen in the last decade (87, 89, 16, 92). 
4.5. Glyceamic control in IDDM: 
   Measuring HbA1c in IDDM adolescents enrolled in the study revealed 51.2% 
had poor control, 31.4% fair and 17.4% good control. The mean HbA1cwas 
found to be 9.7±2.8. These results were somehow similar to that reported by 
Mohammed H where mean HbA1c was found to be 10.8±3.2, 60% had 
poor,24%fair and 16% had good control , and Zaki M who reported 58.8% had 
poor, 32.2% fair and 9% had good control ,also Daod O found 52% poor control 
(89  , 16 , 92) . 
  These results were unlike those reported by Abu Samra where mean HbA1c 
was 13.3±3.2 and 82.4% were poor control and only one patient had good 
control (87). The differences were most probably due to the fact that she did her 
study in uncontrolled patients who presented with DKA. Also, Elamin reported 
mean HbA1c of 12±1.9, which is higher than reported in this study (34). This 
explained by the improvement of diabetic control that occurred during the last 
decade & by the difference in laboratory method used by the two studies. 
     Olsen B in similar study (1999) reported mean HbA1c in Danish was 
9.7+1.7%, only 11% had good control. Also, Bouhanick B in 2003 reported 
 mean HbA1c in French was 8.6+1.8%and 34%of patients had unsatisfactory 
control. (76, 93) These almost similar to ours.  
4. 6. Weight and height percentiles distribution in IDDM: 
    Regarding growth parameters in IDDM, this study showed that 69.8% had 
<25th centile for weight and 55.8% for height. One patient showed >90th centile 
for weight, these almost the same as Abu Samra's, and Daod's studies  results, 
where 73.5% plotted < 25th centile for weight and 32.95 <25th centile for the 
height in the former study, and 79.5%for weight , 62.8% showed heights <25th 
centile in the later study. Abu Samra also found one patient over weight (87, 92).                    
These findings reflect the poor diabetic control and chronic under treatment with 
insulin, did not improve satisfactory during the period between three studies 
(1997, 2002, 2005). 
4. 7.   Prevalence of MAU in IDDM adolescents: 
     This study revealed a high prevalence of MAU (38.4%) which is slightly 
higher than that reported by Elamin in 1993 (25.5%) and that reported by Olsen 
B14%  in Danish and prevalence of 12.5% by Joner G in Norwegian       
population and of  9% by Olsen Bin  Danish population (34, 75, 73, 76) . 
   These differences in the prevalence may reflect the genetic predilection among 
different nations and may be partially explained by using different techniques in 
detecting MAU and the differences in the cut off point definition of MAU. 
 4. 8. The influence of Age, sex and duration on development of 
MAU: 
    In this study, prevalence of MAU increased with age, reaching 50% in the age 
group 15-18years old. The youngest patient with MAU was 9 years old. No sex 
differences revealed in the development of MAU. 
Duration appeared to affect the development of MAU that the prevalence 
increased to 71.4% in those with >9years duration of DM. Statistically no 
significance correlation found to sex, age or duration of DM. 
   These results were not similar to that reported by Elamin A, were MAU 
correlated positively with age and duration and reported no gender differences. 
(34) 
Olsen B in2004 also reported that MAU in Danish was not found in those less 
than 15years old and simulate our series in that it was not correlate with 
duration. However, in his study in the same Danish group 1999reported that 
MAU correlated positively with age, & duration (75, 76). 
   And simulated Joner G who found no differences in age, sex and duration (73). 
Osman W reported that female gender was found to be confounder of MAU, but 
this may not be typical in children (70). 
 
 4. 9. The influence of HbA1c and arterial blood pressure on 
development of MAU:  
   This study revealed that MAU positively correlated with HbA1c (p= 0.007) 
and independently affected by arterial blood pressure (systolic and diastolic) 
   These results were somehow similar to those reported by Elamin A where 
HbA1c and both systolic and diastolic blood pressure was found to be associated 
factors, and results of Olsen B where HbA1c and diastolic  BP was found to be  
associated factors ,and Joner G who found HbA1c and BP were significantly 
higher in microalbuminuric patients(34, 76, 73). 
   Differed from Olsen's B, et al 1999 in Danish, who reported that only diastolic 
component was significantly associated with MAU, no association with HbA1c 
elicited And simulated his study in Danish patients2004 where significant 
association with HbA1c was found(76, 75). 
  The different findings reported in different populations & within one 
population after many years, reflected the fact that the genetic factors are more 
significant and dilute the significance of glyceamic control changing over strict 
programs.   
 
 
 
 4. 10    Prevalence of Retinopathy in IDDM: 
   This study revealed a prevalence of 6.4% of diabetic retinopathy in IDDM 
adolescents in Sudan. 
  This prevalence is lower than reported by Elamin (11%) and much higher than 
that reported by Daod (2.9%) in Sudanese 1DDM patients (34, 92). 
Also, the prevalence of retinopathy is lower than that found in other nations that 
Olsen B in Danish 2004 reported 17.7%, Joner in Norwegian report a prevalence 
of 32.8% in age 8-30 years and 60% by Olsen B   in Danish 1999, and 44% by 
Ben Hamuda  in Tunisian diabetics. (75, 73, 76, 71)    
   The differences in prevalence explained by the different methods used in the 
studies that the use of Florescein angiography, which detects even slight changes 
and the age groups, studied. 
4. 11 The influence of sex, age and duration on development of 
diabetic retinopathy:  
   The prevalence was found to be increased with age given a prevalence of 
22.2% in age group 15-18 years old, statistically age was found to be nearly 
significant. 
  All patients with retinopathy had diabetes for more than 9years given a 
prevalence of 60% in those >9yrs duration .Duration found to be significantly 
 associated with diabetic retinopathy (P=0.001), no differences was found 
between the two sexes. 
  These findings shown to be similar to studies done in Danish diabetic children 
by Olsen who showed significant relation with duration of DM and an increased 
prevalence with age 17.7% in 12-15 years and 16-20 years was 45.4%,and the 
study of Joner in Norwegian population who reported duration of DM and age to 
be significantly correlated factors(75, 73). 
4.12  Glyceamic control and BP in relation to diabetic 
retinopathy: 
  Studying IDDM adolescents HbA1c and its relation to DR revealed no 
significant correlation, also the study showed near significant association with 
systolic BP (P=0.068) and diabetic retinopathy. These results contrasted to 
Olsen's and Ben Hamuda who found significance correlation with HbA1c. (75, 71) 
These differences may explained the fact that diabetes duration is more 
significant and ameliorates the effect of HbA1C in Sudanese diabetics. 
4. 13     Microalbuminuria in relation to diabetic retinopathy: 
  In this study, 66.6% of patients with background retinopathy were found to 
have microalbuminuria, no significant correlation elicited statistically.  
 In contrast, Elamin found retinopathy in 23% of the microalbuminuric patients 
and found significant correlation statistically & Olsen who also reported 
retinopathy to be a factor of developing MAU (34, 76). 
    These differences in studies results may be related to the sample size of 
diabetic retinopathy in our study.  
 • Conclusions 
 
   Prevalence of microalbuminuria and diabetic retinopathy was studied in 86 
IDDM adolescents with mean age 13.6± 2.6 years and mean duration of 4.4± 3.4 
years. 
    The majority of IDDM adolescents were originally sloped from Arabic tribes, 
had unsatisfactory school attendance and performance. 
    Majority had family history of diabetes mellitus and had no family history of 
hypertension, diabetic retinopathy or nephropathy. 
   Twice –dose per day applied by the majority and needed 0.5-1 IU insulin/kg/ 
day. Many did not comply with their doses of insulin mostly due to financial 
causes and ignorance 
   The majority showed poor growth and delayed sexual maturity. 
More than half of the study group had poor glyceamic control and many had 
joint immobility. 
   Prevalence of microalbuminuria was found to be 38.4%.MAU correlated 
positively with glyceamic control of diabetes P= 0.007. Gender, duration, and 
arterial BP had no effect on the development of MAU. 
Family history of DM was found to be significantly correlated with the 
development of MAU. 
    Background retinopathy occurs in frequency of 6.4%, it was found to have 
significant correlation with diabetic duration, joint immobility and near 
significant with systolic BP. 
  Sex, age and glyceamic control had an independent effect to diabetic 
retinopathy. 
 
 Recommendation  
 
• This study strongly recommends early strict glyceamic control, 
to prevent the development and progression of diabetic 
nephropathy. 
• It is high time to establish three or more insulin doses per day or 
basal bolus regimen (as has been shown that none of the 
participant follow it) to well-motivated children and parents. 
• Establishment of an intensive diabetic education program, 
concentrating on self-monitoring and insulin adjustment as well 
as diet. 
• We recommend establishing of regular screening programs for 
early detection of microalbuminuria and retinopathy.                                
• Finally we highly recommend a multidisciplinary approach and 
regular check up by ophthalmologists for older children 
 
 References 
 
1. Foster DW .Diabetes mellitus. In : Braunwald E , Issebacher KJ 
, Petersdorf RG , et al ,eds. Harrison's Principles of Internal 
Medicine2, 11th edition. New York: Mc Graw-Hill Book 
Company, 1987:1778-97. 
2. Raine EJ, Donaldson MD, Gregory JW, Savage MO. Diabetes 
Mellitus. In : Raine EJ , Donaldson MD, Gregory TW , et al, 
eds. Practical Endocrinology and Diabetes in Children, 1st 
edition. London: Blackwell Science Ltd, 2001: 1-28. 
3. Philip K. Disorder of Carbohydrate metabolism: diabetes 
mellitus. In: Paul B, Benson MD, Walsh MC, et al, eds. Text 
Book of Medicine. Philadelphia: W.B. Saunders Company, 
1971:1639-40. 
4. Donald A, McLain E. The endocrine pancreas:  Insulin and 
glucagon. In:  Michael PC, Shalmo M, eds. Endocrinology 
Basic and Clinical Principles,1st edition. New Jersy: Hunene 
Press, 1997:249-55. 
 5. Michael B. Discovery of Insulin. In: John C, Gareth W, Pick up, 
eds. Text Book of Diabetes,1st edition. London: Oxford 
Blackwell Scientific Publications, 1991:13-243. 
6. Sperling MA. Diabetes mellitus. In: Behraman RE, Kliegman 
RM, Jenson HB, eds. Nelson's Text Book of pediatrics, 16th 
edition. New York:  W.B. Saunders Company, 2000:1767-91.  
7. Daoud OHM. Acute and delayed complication of type I (insulin 
dependent) diabetes mellitus in children and adolescents. MD 
thesis of Pediatrics and Child Health, U of K, 1997. 
8. Unger RH, Foster DW. Diabetes mellitus. In: Wilson JD, Foster 
DW, KronenbergHM, et al, eds. Williams Text Book of 
Endocrinology, 9th edition. Philadelphia: W.B Saunders 
Company, 1998: 973-1059. 
9. National Diabetes Data Group. Classification and diagnosis of 
diabetes mellitus and other categories of glucose intolerance. 
Diabetes 1979; 28:1039-57. 
10. Elamin A, Omer MI, Hofuader Y, et al. Epidemiology of IDDM in 
school children in Khartoum, Sudan. Diabetes Care 1989; 
12(6): 430-2.  
 11. Elamin A, Omer MI, Zein K, et al. Epidemiology of childhood 
type 1 Diabetes in Sudan 1987-1990. Diabetes care 1992; 15: 
1556-9. 
12. Tuomilehto J, Zimmet p, Mackay IR, et al. Antibodies to 
Glutamic acid decaboxylase as predictors of insulin dependent 
diabetes mellitus before clinical onset. Lancet 1994; 343:1383-
5. 
13. vondewalk CL, Decraene T, Schuit FC,et al. Insulin 
autoantibodies and high titer islet cell antibodies are 
preferentially associated with the HLA DQA1*0301-DQB1*0302 
haplotype at clinical onset of type I (insulin dependent ) 
diabetes mellitus before age 10 years but not at onset between 
age 10 and 40 years. Diabetolgia 1997; 36:1155-62. 
14. Magzoub MM. Identification of genetic susceptility loci for type I 
insulin dependent diabetes mellitus in Sudan. MD thesis in Path 
U of G 1991. 
15. Elamin A, Omer AI, Tovem T. Islet-cell antibodies and 
endogenous insulin secretion in Sudanese diabetic children. 
Diabetes Res Clin Pract 1992; 16(2): 91-6. 
 16. Zaki M. Glutamic acid decarboxylase and thyroid antibodies in 
Sudanese diabetic children. MD thesis of pediatrics and child 
health, U of K 1999. 
17. Kheir KM. Children with diabetic ketoacidosis presenting to 
children emergency hospital in Khartoum. MD thesis in 
Pediatrics and Child Health, U of K 1993. 
18. Report of the Expert Committee on The diagnosis and the 
classification of diabetes mellitus. Diabetes care 1997; 
20:1183-97. 
19. Platnick LP. Type I (insulin dependent) diabetes mellitus. In: 
McMillan JA, De Angelio CD, Feign RD, Warshaw JB, eds. 
Oski's Pediatrics: Principles and Practice, 3rd edition. 
Philadelphia: The Sheridan press, 1999:1773-1803. 
20. American Diabetes Association. Diabetic nephropathy. 
Diabetes care 2002; 25:85-6. 
21. Lestradet H, Papoz L, Hellouis de Menibus C, et al. Long-term 
study of mortality and vascular complications in juvenile onset 
(type1) diabetes. Diabetes 1981; 30:175-9. 
 22. Bojestig M, Arnqvist HJ, Hermansson G,et al. Declining 
incidence of nephropathy in insulin dependent diabetes 
mellitus. N Engl J Med 1994; 330:15- 18. 
23. Saski A, Uehara M, Horiuchi N, et al. Long terms follow up 
study of Japanese diabetic patients: mortality and causes of 
death. Diabetologia 1983; 25:309-12. 
24. Jaffa AA, Ruse PF, Mayfield Rk, Kinin F. A mediator of 
diabetes –induced glomerular hyperfilteration. Diabetes 1995; 
44:156-60. 
25. Salina-Madrigal L, Pirani CL, Pallak VE. Glomerular and 
vascular ((insudative)) lesion of diabetic nephropathy: electron 
microscopic observations. Am J pathol 1970; 59: 369-97.  
26. Osterby R. Early phases in the development of diabetic 
glomerulopathy. Acta Med Scand 1974; suppl 574: 3-82. 
27. Mauen SM, Miller K, Goetz FC, et al. Immunopathology of renal 
extracellular membranes in kidney transplanted into patients 
with diabetes mellitus. Diabetes 1976; 25:709-12.  
28. Hostetter TH, Rennke HC, Brenner BM. The case for intrarenal 
hypertension in the intiation and progression of diabetic and 
other glomerulopathies. Am J Med 1982; 27: 375-80. 
 29. Vibenti GC, Walker JD.Diabetic nephropathy: etiology and 
prevention. Diabetes Metab Rev 1988; 4:147-62. 
30. Mogensen CE. Progression of nephropathy in long-term 
diabetics with protienuria and effect of initial antihypertensive 
treatment.  Scand J Clin Lab Invest 1976; 36: 383-8. 
31. Deen WM, Bohrex MP, Brenner BM. Macromolecule transport 
across glomerular capillaries: application of pore theory. Kidney 
Int 1979; 16: 353-65. 
32. Dahi-Jorgensen K, Hanssen KF, Kierulf P,et al. Reduction of 
urinary albumin excretion after 4 years of continuous 
subcutaneous insulin infusion in insulin–dependent diabetes 
mellitus . Acta Endocrinol 1988; 117:19-25. 
33. Wiseman MJ, Saunders AJ, Keen H, et al. Effect of blood 
glucose control on increased glomerular filtration rate and 
kidney size in insulin dependent diabetes. N Eng J Med 1985; 
312:617-21. 
34. Elamin A, Ali MI, Ismail B. Microalbuminuria in young Sudanese 
patients with type 1 diabetes. Annals Saudi Med J 1993; 
13(6):493-6. 
 
 35. Keen H, Chlouverakis C. An immunoassay method for urinary 
albumin at low concentrations. Lancet 1963; 2: 913-6. 
36. Viberti GC, Hill RD, Jarrett RJ, et al. Microalbuminuria as 
clinical predictor of clinical nephropathy in insulin dependent 
diabetes mellitus. Lancet 1982; 1:1430-2. 
37. Mathiesen ER, Oxenboll B, Johansen K, et al. Incipient 
nephropathy in type 1 (Insulin dependent) diabetes. 
Diabetologia 1984; 26: 406-10. 
38. Schultz CJ, Amin R, Dunger DB. Markers of microvascular 
complications in insulin dependent diabetes. ACE 2002. 87:10-
2. 
39. Palmberg PF. Diabetic retinopathy. Diabetes 1977; 26:703-9. 
40. Davis MD. Diabetic retinopathy: a clinical overview. Diabetes 
Metab Rev 1988; 4:291-322. 
41. Pettitte DG, Knowler WC, Lisse JR, et al. Development of 
retinopathy and protienuria in relation to plasma glucose 
concentration in Pima Indians. Lancet 1980; 2:1050-2. 
42. Burditt AF, Caird FI, Draper GJ. The natural history of diabetic 
retinopathy. QJ Med1968; 37:303-17. 
 43. Klein R, Klein BEK, Moss SE ,et al.The Wisconsin 
epidemiologic study of Diabetic Retinopathy II : Prevalence and 
risk of diabetic retinopathy when age at diagnosis is less than 
30 years. Arch Ophthalmol 1984; 102:520-6. 
44. Little HL. Proliferative diabetic retinopathy: Pathogenesis and 
treatment. In: Little HL, Jack RL, Patz A, et al, eds. Diabetic 
Retinopathy,1st edition. New York: Thieme-stratton, 1983:257-
73. 
45. Ashton N. Pathogenesis of diabetic retinopathy. In: Little HL, 
Patz A, Jack RL, et al, eds. Diabetic Retinopathy,1st edition. 
New York: Thieme-Stratton, 1983:85-106. 
46. Mc Millan DE. Plasma protein changes, blood viscosity and 
diabetic macroangiopathy. Diabetes 1976; 25(2):858-64. 
47. Little HL. Role of blood elements in the pathogenesis of 
diabetic retinopathy. In: Little HL, Patz A, Jack RL, et al, eds. 
Diabetic Retinopathy,1st edition. New York: ThiemeStratton, 
1983:136-47. 
48. Schmid-Schonbein H, Volger E. Red-cell aggregation and red 
cell deformability in diabetes. Diabetes 1976; 25 (2): 897-902. 
 49. Mc Millan DE, Utterback NG, La Puna J. Reduced erythrocyte 
deformability in diabetes. Diabetes 1978; 27:895-901. 
50. Petersen CM, Jones RL, Koenig RJ, et al. Reversible 
hematologic sequelae of diabetes mellitus. Ann Intern Med 
1977; 86: 425-9. 
51. LittLe HL. The role of abnormal hemorrheodynamic in the 
pathogenesis of diabetic retinopathy, 1st edition. Trans Am 
Ophthalmol Soc 1976; 74: 573-636. 
52. ALmer LO, Panddfi M. Fibrinolysis and diabetic retinopathy. 
Diabetes 1976; 25 (2): 807-10. 
53. Stem MP. Diabetes and cardiovascular disease. Diabetes 
1905; 44: 369-74. 
54. Kwan HC. Changes in blood coagulation, platelet function and 
plasminogen-plasmin system in diabetes. Diabetes 1992; 41: 
32-5. 
55. Lufkin EG, Fass DN, O'Falln WM, et al. Increased Von 
Willebrand factor in diabetes mellitus. Metabolism 1979; 
28:733-8. 
 56. Butkus A, Skrinska VA, Schumacher OP. Thromboxane 
production and platelet aggregation in diabetic subjects with 
clinical complications. Thromb Res 1980; 19: 211-23. 
57. Johnson M, Harrison HE, Raftery AT, et al. Vascular 
prostacyclin may be reduced in diabetes in man. Lancet 1979; 
1: 325-6. 
58. Dukes ID, McIntvre MS, Mertz RJ, et al. Dependence on NADH 
produced during glycolysis for beta-cell signaling. J Biol Chem 
1994; 269: 1079-82. 
59. DitzeL J .Oxygen transport impairment in diabetes. Diabetes 
1976; 259 (2): 832-8. 
60. Davis MD. Diabetic retinopathy: Clinical overview. Diabetes 
Metab Rev 1988; 4: 291-322. 
61. Ishibashi T, Tanaka K, Taniguchi Y. Disruption of blood retinal 
barrier in experimental diabetic rat: an electron microscopic 
study. Exp Eye Res 1980; 30: 401-10. 
62. Wallow IHL, Engerman RL. Permeability and Patency of retinal 
blood vessels in experimental diabetes. Invest Ophthalmol Vis 
Sci 1977; 16: 447-61. 
 63. Wautier JL, Zoukourian C, Chappey O, et aL. Receptor-
mediated endothelial cell dysfunction in diabetic vasculopathy, 
soluble receptor for advanced glycation end products blocks 
hyperpermeability in diabetic rats. J Clin Invest 1996; 97: 238-
43. 
64. Mac Gregor LC, Rosecan LR, Laties AM, et aL. Altered retinal 
metabolism in diabetes choroids and retina. J Biol Chem 1986; 
261: 4046-51. 
65. Cunha-Vaz JG, Mota CC, Leite EC, et al. Effect of sorbinil on 
blood retinal barrier in early diabetic retinopathy. Diabetes 
1986; 35: 574-8. 
66. Dornan TL, Ting A, McPherson CK, et Al. Genetic susceptility 
to the development of retinopathy in insulin-dependent 
diabetes. Diabetes 1982; 31: 226-31. 
 
67. Pyke DA. Diabetes: The genetic connections.Diabetologia 
1979; 17: 333-43. 
68. Waltman RS, Oestrich C, Krupin T, et Al. Quantitive Vitreous 
fluorophotometry. Diabetes 1978; 27: 85-7.  
 69. Mandelcorn MS. Blankenship GR. Pars Plana Vitrectomy for 
the management of sever diabetic retinopathy. Am J 
Ophthalmol 1976; 81: 561-71. 
70. Haroun WO. Microalbuminuria as a predictor of diabetic 
nephropathy in Sudanese patients. MD thesis in Medicine, U of 
k, Khartoum –Sudan, 1994. 
71. Ben Hamuda, Messaud R, Ayadi A, et al. Prevalence and risk 
factors of diabetic retinopathy in children and young adults. 
Ophthalmol 2001; 24 (4):367-70  
72. EL-Asrar AM , AL-Rubeaan KA, AL-Amro SA, et al. 
Retinopathy as a predictor of other diabetic complications. Int 
Ophthalmol 2001; 24(1):1- 
73. Joner G, Brinchman –Hansen O, Torres CG, et al. A Nation 
wide cross sectional study of retinopathy and  microalbuminuria 
in young Norwegian type 1 insulin dependent  diabetic patients 
.Diabetologia   1999 ; 35 (1) :1049-54. 
74. Salardi S, Rubbi F, Puglioli R, et al. Diabetic retinopathy in 
childhood: long-term follow up by florescein angiography 
beginning in the first months of disease. J Pediatr Endocrinol 
Metab 2001; 14 (5): 507-15. 
 75. Olsen BS, Johannessen J, Sjolie AK, et al. The significance of 
the prepubertal diabetes duration for the development of 
retinopathy and nephropathy in patients with type 1 diabetes - 
Danish Study Group of Type 1 Diabetes Mellitus in Childhood. 
J Diabetes Complications 2004; 18(3):160-4. 
76. Olsen BS, Johannsen J, Sjolie AK, et al. Metabolic control and 
prevalence of microvascular complication in young Danish 
patients with type 1 diabetes mellitus –Danish Study Group of 
Diabetes in Childhood. Diabet Med 1999; 16 (1):79-85.  
77. Campos- Pastor MM, Escobar-Jimenez F, Mezquita P, et al. 
Factors associated with microalbuminuria in type 1 diabetes 
mellitus: a cross-sectional study. Diabetes Res Clin Pract 2000; 
48(1): 43-9. 
78. Svesson M, Eriksson JW, Dahlquist G. Early glyceamic control, 
age at onset and development of microvascular complications 
in childhood–onset type 1 diabetes: a population-based study in 
northern Sweden. Diabetes care 2004; 27 (4): 955-62.  
79. Porta N, Dalmasso P ,Grassi G ,et al .Prepubertal onset of type 
1diabetes and appearance of retinopathy . Diabetes Metab 
2004; 30(3): 229-33.    
 80. Nordwall M, Bojestig M, Arnquist HJ,et al. Declining incidence 
of sever retinopathy and persisting decrease of nephropathy in 
an unselected population of type 1diabetes mellitus - The 
Linkoping Diabetes Complication study .Diabetologia 2004 ; 
47(7) :1266-72. 
81. Kozek E, Gorska A, Fross K, et al. Chronic complications and 
risk factors in patients with type 1 diabetes mellitus - 
retrospective analysis. Przeql Lek 2003; 60(12): 773 -7. 
82. Donaghue KC, Fairchild JM, Craig ME, et al .Do all prepubertal 
years of diabetes duration contribute equally to diabetes 
complication? Diabetes Care 2003; 26(4): 1224-9.  
83. Cambiaso CL, Collet D, Lievens M. Immunoassay of low 
concentration of albumin in urine by latex particle counting. Clin 
Chem 1988; 34(2):416-8. 
84. Fabiny DL, Ertingshausen G. Automated reaction-rate method 
for determination of serum creatinine with CentrifiChem. Clin 
Chem 1971; 17:696-700. 
85. Bisse’ E, Abraham EC. New less temperature-sensitive 
microchromatographic method for the separation of 
 glycosylated hemoglobin using a non-cyanide buffer system. J 
Chromatog 1985; 344:81-91. 
86. Eshoj O, Feldt-Rasmussen B, Larsen ML, et al .Comparison of 
overnight, morning and 24hrs urine collections in assessment 
of diabetic microalbuminuria. Diabetic Med 1987; 4:531-3.  
87. Abu-Samra SO. Serum ketone bodies associated with diabetic 
ketoacidosis in Sudanese children. MD thesis in pediatrics and 
child health, University of Khartoum-Sudan, 2002.    
88. 88.Salman H, Abnamy A, Ghassan B, et al. Insulin-dependent 
diabetes mellitus in children : Familial and clinical patterns in 
Riyadh. Annals of Saudi Medicine 1991; 11(3):302-6. 
 
89. Mohammed H A. Knowledge attitude and practices among 
diabetic children and their relation to glyceamic control. MD 
thesis in pediatric and child health, University of Khartoum-
Sudan, 2003.    
90. Abdulla MA. The clinical presentation of childhood diabetes 
mellitus in Riyadh, Saudi Arabia. Saudi Med J 1989; 10(6):495-
7. 
 91. Weber B. Pathophysiology of diabetes mellitus. In: Brook G, et 
al. Clinical pediatric endocrinology, 2nd edition. Oxford: 
Blackwell, 1989: 555-82. 
92. Daud O. Acute and delayed complications of type 1 diabetes in 
children and adolescent. MD thesis in pediatric and child 
health, University of Khartoum-Sudan, 1997.    
93. Bouhanick B, Raguin H, Rohmer V, et al. Description of 
microangopathy in children with type 1 diabetes mellitus: a 19-
year retrospective study. Diabetes Metab 2003; 29(4pt 1):395-
402. 
 
 
 
 
 
 
 University of Khartoum 
Postgraduate medical studies 
Department of pediatric &child health 
Prevalence of micro albuminuria &retinopathy 
In IDDM adolescents in Khartoum state 
 
1. Serial No ………………………………………………………………
 
2. Date…………………………………………………………………….
 
3.  Name………………………………………………………………….
 
4. Age group (in yrs)  (1) 10 ~ 12          (2) 12 ~ 14          (3) 14 ~ 16 
                  
5. Sex   (1) male               (2) female 
 
6. Origin    (1) north    (2)south  (3)east  (4)west  (5)centre  
7. Tribe…………………………………………………………………...
 
8. Residence………………………………………………………………
 
9. Tel.NO…………………………………………………………………
 
10. monthly income(S\D)  
             
                (1) <35000     (2) 35000 – 100000    (3) >100000 
11. schooling:- 
 
(A) Level of education 
  
            (1) Not educate      (2) Basic      (3) Secondary 
 
         (B) Schooling after the illness                  
        
            (1) Interrupted          (2) stopped          (3) regular 
 
       
        (C) Level of performance 
 
(1) Excellent       (2) V.G        (3) good        (4) poor                        
 Per diabetic 
    
Post diabetic  
 
 
 
12.  Duration of DM (in yrs)                                                            
       
       (1) <1 yrs        (2) 1 – 5    (3) 5 – 9      (4) > 9 yrs 
 
13. No of DKA Per last year. 
          
       (1) Non           (2)< 3       (3) 3 ~ 5       (4) > 5 
 
14. No of hospital admition  
       
      (1) Non           (2) ≤ 2      (3) 3 ~ 5        (4) > 5 
 
15. F.H of DM   
 
     (1) +ve 1st degree        (2) +ve2nd degree        (3)-ve  
  
16. F.H of diabetic nephropathy 
 
                  (1) +ve 1st degree         (2) +ve2nd degree       (3) –ve 
 
17. F.H of hypertension 
      
     (1)+ve 1st degree         (2) +ve 2nd degree         (3)-ve 
 
18. F.H of diabetic retinopathy 
 
                  (1) +ve 1st degree        (2) +ve2nd degree         (3)-ve 
 
19. Current insulin dose/day 
 
                         (1) Once                       (2) twice                      (3) more 
 
20. Dose (u/kg) 
         (1) < 0.5/kg       (2) 0.5~1/kg      (3) 1~2/kg       (4) >2/kg 
 
21. Compliance to insulin:- 
  
       (1) Compliant       (2) non compliant          
 
22. Causes of noncompliant:- 
 
         (1) Financial             (2) ignorance    (3) refused by the child 
       
        (4) False believes             (5) others 
 
23. Storage of insulin:- 
 
        (1) Adequate              (2) not adequate  
 
24.  Compliance to Diet:- 
      
        (1) Good           (2) fair          (3) poor   
                         
 
 25. HT…………………..                           Percentile…………………….. 
 
26. WT…………………..                           Percentile…………………….. 
  
27. BP……………………                           Percentile…………………….. 
 
28. SMR:- 
 
    (1) Stage1   (2) stage2    (3) stage3     (4) stage3     (5) stage5  
 
29. Cataract: 
          
       (1) Present               (2) not present 
 
30. Fungus:- 
 
     (1) Background retinopathy     (2) proliferate          (3) normal 
 
31. CVS: 
 
      (A)  1. Cardiomegaly                2. No cardio megaly   
      
      (B)  1. Heart failure                  2. Not in failure  
 
 32. Joint immobility: 
 
         (1) Present                 (2) not present 
 
 
 
       
 
HbA1C% 
1.   <7.1                        2.  7.1<9.1                       3.  > 9.1 
 
1. Urine analysis  
    
  1.+ve 2. -ve Remarks  
a puss    
b RBC    
c protein    
d sugar    
f acetone    
 
 2. MAU 
 
 Remarks  
MAU ug/l 1. <20 2.  20-199           3.  >199  
A/C Q 1.  <30 2.  30-299 3. >299 
 
 
24hr albmg/24hr 1. <30            2. 30-299            3. >299  
 
 
 
